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ABSTRACT

Fritz, Brandon M. Ph.D., Purdue University, May 2016. The Effect of Voluntary Binge
Caffeine and Ethanol Co-Exposure on Neurobehavioral Sensitivity to Cocaine in Male
C57BL/6J Mice. Major Professor: Stephen L. Boehm II.

Recently, the co-consumption of highly caffeinated energy drinks and alcohol has
become a public health concern. Consumption of these beverages has been linked to a wide
variety negative consequences including alcohol poisoning, driving under the influence,
physical harm, and sexual violence. The more protracted consequences of caffeinated
alcohol consumption have received very little attention, however. Some evidence suggests
that individuals that frequently consume energy drinks mixed with alcohol are more likely
to develop an alcohol use disorder. Interestingly, both caffeine and alcohol use alone have
been linked to polydrug abuse. It is therefore of interest whether combined caffeine and
alcohol consumption may pose an additive risk for substance abuse. Given that both
compounds can positively influence dopamine signaling in mesolimbocortical reward
circuitry via different mechanisms, this is an important question to address.
Psychostimulants, such as cocaine, are of particular interest considering the significant
involvement of dopamine in their effects. The current project explored this possibility
employing an established mouse model of binge caffeine and alcohol co-consumption.
Male C57BL/6J mice underwent 14 days of daily, 2hr limited access to water, alcohol,
caffeine, or combined caffeine and alcohol. Water was freely available after these sessions.
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In Experiment 1, mice underwent an 11-day locomotor sensitization protocol for cocaine
initiating on day 15. Locomotor sensitization has been associated with a greater propensity
to self-administer psychostimulants in rodents. Mice were subjected to injections of
cocaine (5 or 10 mg/kg; i.p.) or saline every other day, with 15 minute activity monitoring
until day 25. In Experiment 2, a separate group of mice underwent an identical drinking
procedure. A conditioned place preference (CPP) protocol commenced on day 15. CPP
assesses the conditioned rewarding effects of cues associated with drugs of abuse. On day
15, mice received saline injections and were immediately placed onto a neutral floor texture
(paper) in the place conditioning box for 15 minutes in order to habituate the animals to
the apparatus and injection procedure. Starting on day 16, mice received daily alternating
systemic injections of cocaine (1 or 5 mg/kg; i.p.) and saline or saline throughout (naïve
controls) and were placed onto one of two particular tactile floor cues: a metal floor with
holes punched out or a grid floor made of metal rods. Mice were exposed to the other
injection/floor pairing on the alternate days. Mice were placed into these activity monitors
for 15 minute conditioning sessions. These sessions alternated drug and vehicle over the
course of 8 days so that a total of 4 drug and 4 saline injections were given. The first place
preference test occurred on day 24 wherein all mice were injected with saline and offered
access to both floor textures. On day 25, mice were returned to the conditioning protocol
for another 8 days and a second CPP test on day 33. The results of Experiment 1 suggested
that prior caffeine consumption, irrespective of the presence of ethanol, enhanced the initial
psychomotor stimulating effect of 10 mg/kg cocaine. However, prior fluid consumption
history did not influence the capacity to develop locomotor sensitization. The results of
Experiment 2 indicate that prior caffeine and/or ethanol consumption had no influence on
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the development or expression of CPP for 1 mg/kg or 5 mg/kg cocaine. Collectively, these
results suggest that a history of caffeine consumption may increase the stimulant response
to a moderate dose of cocaine, perhaps indicating cross-sensitization. Although the
conditioned rewarding effects of cocaine were not altered by prior caffeine and/or ethanol
consumption, an enhanced stimulant response may be indicative of enhanced cocaine abuse
potential. This study demonstrates that moderate caffeine consumption may influence an
individual’s early interactions with cocaine which may eventually influence the likelihood
of later problematic use.

1

INTRODUCTION

General Introduction
The public health impact of alcohol (ethanol) abuse is both far-reaching and
extraordinarily expensive. In its 2014 global status report, the World Health Organization
attributed 3.3 million deaths per year to ethanol use/abuse worldwide and in the United
States (U.S.) alone, the economic burden of ethanol consumption has been estimated at
223.5 billion dollars (Bouchery et al., 2011). It is therefore clear that ethanol use/abuse is
a serious issue that warrants study to mitigate these costs to the economy and public health.
A specific subtype of ethanol consumption, binge drinking, is quite common with
1 in 6 adults reporting engaging in binge drinking in the U.S. In addition, the Center for
Disease Control and Prevention declared that binge drinking accounts for more than half
of estimated annual deaths attributed to excessive ethanol drinking in the U.S. (CDC, 2012).
This form of excessive drinking has been linked to a variety of acute consequences, such
as driving under the influence and physical harm (CDC, 2015), as well as later drinking
problems (Chassin et al., 2002). Binge drinking is characterized by consuming a large
amount of alcohol in a short period of time, with the ultimate goal of reaching intoxication.
The official definition of binge drinking by the National Institute on Alcohol Abuse and
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Alcoholism is a pattern of drinking that brings blood ethanol concentration (BEC) levels
to 0.08 g/dl within a period of 2hrs, which can typically be achieved by consuming 4 drinks
for women and 5 drinks for men. This level of intoxication typically produces impaired
reaction time, motor coordination, and attentiveness (Moskowitz and Fiorentino, 2000).
Therefore, this BEC level is the nationally-accepted limit for automobile operation for good
reason. A troubling trend in binge drinking has recently emerged with the common practice
of consuming ethanol and highly caffeinated ‘energy drink’ mixed beverages.

Caffeinated Alcohol Consumption and its Consequences
Following numerous reports in the media about increases in alcohol poisoning and
physical harm associated with the consumption of pre-mixed caffeinated alcoholic
beverages (e.g. Joose, Four Loko), the FDA mandated that companies remove the large
amount of caffeine from such beverages in 2010. This measure offered little in the way of
regulation, however, as these alcohol/energy drink mixers can be readily prepared by
individuals as the ingredients (liquor and energy drinks) are widely available.
Consumption of these beverages has been associated with an increased risk for
hazardous behavior such as drinking to the point of alcohol poisoning (CDC, 2012), driving
under the influence (O'Brien et al., 2013; O’Brien et al., 2008; Thombs et al., 2010;
Woolsey et al., 2015), sexual promiscuity (O'Brien et al., 2013), and aggression (Jones et
al., 2012; Miller et al., 2016). Particularly concerning is that the analyses in the above
studies controlled for overall alcohol intake, thereby suggesting greater concern regarding
caffeinated versus alcohol-only intoxication. It has been contested, however, that these
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findings may simply be confounded by a generally greater sensation seeking tendency for
people who choose to consume these highly caffeinated mixed drinks (Alford et al., 2012;
de Haan et al., 2012; Verster et al., 2012a; Verster et al., 2012b). Therefore, individuals
who are already prone to engage in risky or hazardous behavior, in general, may more
likely to exhibit such behavior when intoxicated by alcohol. Strong evidence against this
theory was recently presented, however, in a study by O’Brien and colleagues (2013).
Employing a large sample size (N = 3,390), caffeinated ethanol consumption was
associated with higher odds of driving under the influence, riding with an intoxicated driver,
being taken advantage of sexually, and sustaining physical injury compared to noncaffeinated alcohol consumption; even after controlling for sensation seeking tendency and
the amount of alcohol consumed. In light of these findings, the consequences of
consumption of highly caffeinated alcoholic beverages warrants ample public health
concern and further study.

Caffeine as the Primary Psychoactive Ingredient in Energy Drinks
The practice of consuming caffeinated alcoholic beverages is not new and quite
common (i.e. rum and cola, Irish coffee, etc.). The introduction of ‘energy drinks’, however,
has influenced how people consume caffeine and ethanol combinations. These beverages
contain large quantities of caffeine (~80-300 mg/container) and are also characterized by
a blend of other naturally-occurring stimulants (e.g. guarana), sugars (e.g. glucose and
fructose), and amino acids (e.g. taurine) (Marczinski et al., 2012). Although manufacturers
claim that these are all ‘performance-enhancing’ ingredients, cognitive assessments have
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determined caffeine to be the primary psychoactive ingredient in these beverages (Attwood
et al., 2012; Giles et al., 2012; Peacock et al., 2013b). The potential for pharmacological
interaction between caffeine and alcohol is enhanced by energy drink co-consumption
given that other common caffeinated mixers like standard cola (~30-50 mg) contain far less
caffeine. These mixed drinks are also often consumed rapidly in a binge fashion (e.g.
‘Jagerbomb’ shots) (O’Brien et al., 2008), thus allowing both caffeine and alcohol to
accumulate quickly in the individual’s system, potentially contributing to the previously
described hazards associated with their co-use.

Motives for Caffeinated Alcohol Consumption
The ample evidence for an elevated risk of negative outcomes as a consequence of
highly caffeinated ethanol consumption highlights the importance of understanding the
motives for its consumption. Self-report data from young adult and college undergraduate
populations point to the antagonism of ethanol-induced sedation (Weldy, 2010), increased
stimulation (Ferreira et al., 2004a; Marczinski et al., 2011), and the ability to engage in
longer drinking sessions (Attwood et al., 2012; Marczinski and Fillmore, 2006) as reasons
for consuming these beverages. A recent study by Droste and colleagues (2014) also
explored whether reported motives for consumption predicted associated harms. They
found that individuals cited 4 core motivation classes for caffeinated alcohol consumption:
hedonistic (consuming caffeinated alcoholic beverages is more pleasurable), social (social
facilitation), energy/endurance (drink/party longer), and intoxication reduction.
Interestingly, hedonistic motives were associated with increased risk for greater
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consumption of these beverages, ethanol dependence, and physical harm. Intoxication
reduction motives were also associated with an increased risk of harm outcomes as well,
suggesting that these individuals’ expectations for caffeinated alcohol intoxication may not
have been met in reality. Experimental evidence for significant alteration of alcohol
intoxication via caffeine co-consumption is mixed, however.

Human Laboratory Studies
Co-consumption of caffeine has been observed to attenuate ethanol-induced
impairments in reaction time (Drake et al., 2003; Heinz et al., 2013; Howland et al., 2011),
short term memory (Drake et al., 2003), wakefulness (Drake et al., 2003; Marczinski et al.,
2012), as well as increase subjective stimulation (Marczinski and Fillmore, 2006;
Marczinski et al., 2011; Marczinski et al., 2012; Peacock et al., 2013a). However, these
effects on cognitive and psychomotor performance (Marczinski and Fillmore, 2006;
Peacock et al., 2013a; Verster et al., 2012b) or subjective intoxication (Alford et al., 2012;
de Haan et al., 2012) have not been consistently reported. One reason for this discordance
is that these studies differ substantially in ethanol and caffeine dosing (target BECs 0.040.12 g/dl; 80-300 mg caffeine). Furthermore, the testing interval following caffeinated
alcohol administration varies greatly (15-90 minutes). It is therefore currently unclear the
degree to which concurrent caffeine exposure may alter alcohol intoxication.
Importantly, very little is known about the protracted consequences of binge
caffeine and ethanol co-consumption and the practice of mixing ethanol with these highly
caffeinated energy drinks is rather new. As such, it is likely that the potential public health
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impact of consuming these beverages has not been fully realized and it is critical that we
advance our understanding of this drug combination. Individuals that often consume these
drinks have been found to be at greater risk for later meeting alcohol use disorder criteria
(Droste et al., 2014). Evidence also suggests that ethanol and energy drink/caffeine use
alone are significantly predictive of later polydrug abuse (Arria et al., 2010; Arria et al.,
2011; Kendler et al., 2006; Kirby and Barry, 2012; McCabe et al., 2006; Reissig et al.,
2009). A major potential concern may therefore be that repeated binge caffeine and ethanol
co-consumption could additively increase an individual’s sensitivity to drugs of abuse. In
order to carefully examine the neurobehavioral consequences of binge caffeine and ethanol
co-exposure, preclinical work with animal models offers substantial power to understand
the cause and effect relationship between caffeine/ethanol consumption and drug
sensitivity.

Preclinical Animal Research on Caffeine and Ethanol Combinations
Through precise biological/chemical manipulations and techniques, rodent models
of ethanol exposure have greatly advanced the field’s understanding of the neurobiology
of ethanol use/abuse in ways that human studies ethically cannot. Furthermore, animal
models of caffeine and ethanol co-exposure circumvent potential confounds inherent in
human studies such as expectancy, personality type, and degree of prior ethanol and/or
caffeine experience which may have also contributed to the aforementioned experiment
variability.
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One of the primary concerns that emerged from the reports on highly caffeinated
ethanol consumption in young adults was dangerous ethanol intake. As such, animal
studies have directly focused on whether caffeine alters ethanol consumption in existing
animal ethanol drinking models. Thus far, findings are mixed with three studies
demonstrating an increase in ethanol intake by caffeine co-exposure (Franklin, 2009;
Kunin et al., 2000; Rezvani et al., 2013), two studies demonstrating no effect of caffeine
(Fritz et al., 2014; Hughes, 2011), and one study showing a caffeine-induced decrease in
ethanol intake (Rezvani et al., 2013). These studies employed either a systemic caffeine
injection prior to ethanol access (Kunin et al., 2000; Rezvani et al., 2013) or offered access
to a caffeinated ethanol solution which was consumed voluntarily (Franklin, 2009; Fritz et
al., 2014; Hughes, 2011). Collectively, these results indicate that neither caffeine
administration route produced a consistent effect on ethanol intake. Furthermore, caffeine
dosing varied widely in these studies (~2-23 mg/kg), adding to the difficulty of
interpretation.
Cognition-based tasks have also found mixed evidence for caffeine’s effect on
ethanol intoxication. Caffeine co-exposure (5-40 mg/kg) was observed to have no effect
on ethanol-induced decrements in learning on the plus maze discriminative avoidance task
(Gulick and Gould, 2009) or novel object recognition in mice (Fritz et al., 2014).
Alternatively, caffeine (5 mg/kg) was found to reduce retrograde memory impairment
induced by ethanol in rats (Spinetta et al., 2008). Finally, the anxiolytic effects of alcohol
on the elevated plus maze were found to persist following caffeine (~8 mg/kg) coconsumption (Fritz et al., 2014).
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The clearest effects thus far in the preclinical literature pertain to caffeine’s
modulation of ethanol’s motor effects. Caffeine has been shown to reduce ethanol-induced
ataxia when administered both systemically (~8-15 mg/kg) and centrally (< 25 µg) (Dar,
1988; Fritz et al., 2014). The sedative effects of ethanol can also be mitigated by caffeine
as indicated by a reversal of ethanol-induced hypnosis via a systemic injection of 25 mg/kg
caffeine (El Yacoubi et al., 2003). Caffeine alone is known to produce locomotor
stimulation in mice (Kuribara et al., 1992; Waldeck, 1974) and this has been observed at
doses as low as 3 mg/kg (Hilbert et al., 2013). Low to moderate doses of ethanol (0.12-2.0
g/kg) can also produce locomotor stimulation in rodents (Phillips and Shen, 1995). A
number of studies have demonstrated that caffeine can have an additive effect on ethanolinduced stimulation over a wide variety of ethanol and caffeine dose ranges (1.0-3.2 g/kg
ethanol; 3-50 mg/kg caffeine) (Hilbert et al., 2013; Kuribara et al., 1992; May et al., 2015;
Waldeck, 1974). However, this additive stimulant effect was not observed to associate with
an increased rewarding value of caffeine/ethanol combinations (3 mg/kg caffeine + 1.75
g/kg ethanol) as assessed by conditioned place preference (Hilbert et al., 2013).
To date, rodent research on concurrent caffeine and ethanol exposure has largely
employed forced, non-contingent administration of caffeine and ethanol via systemic
injections or intragastric gavages (Dar, 1988; El Yacoubi et al., 2003; Ferreira et al., 2004b;
Gulick and Gould, 2009; Hilbert et al., 2013; Kunin et al., 2000; Kuribara et al., 1992; May
et al., 2015; May et al., 2012; Rezvani et al., 2013; Spinetta et al., 2008; Waldeck, 1974).
It is well known that non-contingent administration of ethanol and other drugs can produce
significantly different alterations in behavior and neurobiology relative to selfadministration (Jacobs et al., 2003; Mitchell et al., 2012; Moolten and Kornetsky, 1990;
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Nurmi et al., 1996). Therefore, self-administration models offer greater translational
validity relative to the human experience.

Preclinical Mouse Model of Binge Caffeine and Alcohol Co-Consumption
One of the most widely used and consistently validated binge-like alcohol drinking
animal models is the Drinking-in-the-Dark (DID) mouse model. DID offers mice a 20%
(v/v) ethanol solution for a discrete period of time (1-4 hours; 2 hours in our lab) so that
ethanol consumption occurs during an easily definable time period (Thiele et al., 2014).
This is a key strength as the commonly used continuous access, two-bottle choice ethanol
consumption paradigm makes it difficult to determine peak ethanol dosing and does not
consistently produce sustained, pharmacologically-relevant BECs (Dole and Gentry, 1984);
except in mice specifically-bred for high ethanol intake in this paradigm (Matson and
Grahame, 2013). The C57BL/6J (B6) inbred mouse strain, the strain with which the DID
paradigm was developed, reliably consumes ethanol to the point of behavioral intoxication
and reaches BECs in excess of 80 mg/dl (0.08 g/dl) (Rhodes et al., 2005; Rhodes et al.,
2007). In addition, mice with a repeated history of binge-like drinking via DID demonstrate
motor and metabolic tolerance to ethanol (Fritz et al., 2014; Linsenbardt et al., 2011). This
animal model of ethanol consumption therefore appears to mirror what is defined by the
National Institute on Alcohol Abuse and Alcoholism as ‘binge drinking’ wherein an
individual consumes enough alcohol to reach BECs ≥ 80 mg % and intoxication within a
limited time frame.
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Our lab has previously observed that after repeated binge episodes, B6 mice will
consume the 20% ethanol solution to the point of locomotor sedation (Fritz et al., 2014;
Linsenbardt and Boehm, 2012, 2013). Given that caffeine has been observed to attenuate
ethanol-induced sedation in both humans (Drake et al., 2003; Marczinski et al., 2012) and
animals (Dar, 1988; Dar et al., 1987; El Yacoubi et al., 2003) and individuals cite this as a
motive for caffeinated ethanol consumption (Ferreira et al., 2004a; Marczinski, 2011), our
lab was interested in whether the addition of caffeine to the ethanol solution in DID would
increase ethanol intake by way of antagonizing locomotor sedation. Although the addition
of caffeine (0.03-0.05% w/v; concentrations similar to common energy drinks) was not
observed to have an effect on ethanol intake or attained BEC, caffeine completely reversed
the typical ethanol-induced locomotor sedative response and a clear locomotor stimulant
effect emerged. Caffeine co-consumption (~8 mg/kg in 2hrs) also reduced ethanol’s ataxic
effects as measured by the balance beam task. Furthermore, ethanol-induced anxiolysis on
the elevated plus maze apparatus as well as memory interference in the novel object
recognition task were still apparent when caffeine was co-consumed. This caffeinated
ethanol binge co-consumption model therefore appears to model key facets of the “wide
awake drunk” state that individuals anecdotally seek via highly caffeinated energy drinkethanol co-consumption. As this practice is relatively new, the consequences of such
consumption have yet to be realized. This mouse model will serve as a useful tool to
advance our understanding of the neurobehavioral consequences of voluntary binge coconsumption and the threats they may pose to public health and safety. As previously
mentioned, an unanswered and important question is whether a history binge co-exposure
of caffeine and ethanol may have the capacity to enhance an individual’s sensitivity to
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drugs of abuse. Two of the most widely studied phenotypes in the drug abuse research field
that could address this question, locomotor sensitization and conditioned place preference,
are described and discussed below.

Sensitization
Sensitization in the drug abuse field is essentially defined as an increased response
to a fixed dose of drug as a consequence of repeated exposure. Drugs from a wide variety
of classes can produce a sensitization response that has been proposed to be reflective of
increased incentive salience of drug-paired cues, or a shift from “liking” to “wanting” a
drug (Robinson and Berridge, 1993); a key transitional state in chronic drug abusers. In
preclinical studies, behavioral sensitization has most often been measured as a
progressively increased locomotor stimulant response to a drug as a consequence of
repeated exposure. At certain doses, virtually all drugs of abuse produce locomotor
stimulation in rodents (Robinson and Berridge, 1993; Wise and Bozarth, 1987) and with
repeated exposure, many of these drugs can produce a sensitized locomotor stimulant
response. Behavioral observations of sensitization are often tied to substantial changes in
the neurochemical/neurophysiological response to the drug in animals (Borgland et al.,
2004; Janetsian et al., 2015; Vanderschuren and Kalivas, 2000), such as elevated accumbal
dopamine (DA) levels.
Although direct evidence of behavioral sensitization has been observed in chronic
drug abusers or non-human primates, the results have not been consistent (Bradberry,
2006). It has been argued that many of these studies, however, failed to consider the
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importance of cues that are predictive of either the presence or absence of the drug. Vezina
and Leyton (2009) contend that the human laboratory lacks the necessary drug-paired cues
to consistently observe sensitization in chronic drug abusers as drug consumption never
takes place in such an environment for these individuals, let alone lying in a positron
emission tomography (PET) scanner. Indeed, both sensitized behavioral and
neurochemical responses are difficult to detect in an environment dissociated from prior
drug exposure in animals (Guillory et al., 2006; Stewart, 1992). Studies in animals that
have evaluated the response to drug-paired cues alone have observed conditioned responses
associated with sensitization such as increased locomotion and striatal DA release (Vezina
and Leyton, 2009). These observations have also been extended to humans with drugassociated cues producing elevated mood states and physiological responses such as
increased heart rate (Boileau et al., 2007; Foltin and Haney). Furthermore, studies by
Bolieu and colleagues observed sensitized striatal DA release when amphetamine was
repeatedly given in the context of a PET scan, indicating the importance of drug-paired
cues in a human sensitization response (Boileau et al., 2006; Boileau et al., 2007). As
Vezina and Leyton note, however, the observation that drug-sensitized DA release can be
observed in in vitro slice preparations (Castañeda et al., 1988) demonstrates that the
sensitization response can occur independent of contextual stimuli. Nevertheless, it is
argued that sensitized responses can become entirely regulated by these cues, as outlined
above, which may have the capacity to powerfully motivate drug-seeking behavior.
Sensitization has been proposed to reflect significant neuroadaptation underlying a
transition to an addictive state, wherein drug-paired cues acquire intense motivational
properties, perhaps modeling compulsive drug-seeking (Robinson and Berridge, 1993,
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2001). In rodents, self-administration studies have observed that animals sensitized to
psychostimulants respond more for these drugs (Piazza et al., 1990; Vezina, 2004).
Conversely, self-administration of psychostimulants has also been observed to produce
locomotor sensitization (Hooks et al., 1994; Phillips and Di Ciano, 1996). Sensitization can
be a highly persistent state, lasting up to 1 year (Paulson et al., 1991), that has been
associated with the predictive potential for relapse-like behavior following extinction in an
operant self-administration paradigm (De Vries et al., 1998). However, some more recent
studies have found that sensitized animals do not always demonstrate a significant
reinstatement response (Ahmed and Cador, 2005; Knackstedt and Kalivas, 2007).
Although the relationship between sensitization and self-administration is not completely
clear, it has been argued that sensitization has significant construct validity given the fact
that the neurocircuitry underlying both behaviors is remarkably comparable (Steketee and
Kalivas, 2011). Thus, the neurobiological/neurochemical alterations produced by
locomotor sensitization are also arguably similar.

Cross-Sensitization
One consequence of exposure to drugs of abuse can be cross-sensitization, whereby
a history of drug exposure can result in increased sensitivity to other drugs. Given that
ethanol and caffeine share common effector systems (dopamine, adenosine), co-exposure
may produce neurobiological adaptations to a greater extent than ethanol or caffeine alone
as evidenced by greater behavioral responsivity to another drug. Cross-sensitization has
been theorized to be indicative of increased abuse potential for the new drug(s) (Ferreira et
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al., 2013; Lessov and Phillips, 2003; Robinson and Berridge, 1993; Yang et al., 2011).
Ethanol (Boileau et al., 2003; Ding et al., 2011; Gonzales and Weiss, 1998; Schier et al.,
2013; Yoshimoto et al., 1992) and caffeine (Okada et al., 1996; Quarta et al., 2004; Solinas
et al., 2002) have both been shown to increase dopamine signaling in the ventral striatum
via different mechanisms and experimenter-controlled co-exposure has been demonstrated
to produce an additive locomotor stimulant effect (Hilbert et al., 2013; Kuribara et al., 1992;
May et al., 2015; Waldeck, 1974). Furthermore, repeated intragastric infusions of a
combined caffeine and ethanol solution induced significantly greater locomotor
sensitization than caffeine or ethanol alone in mice (May et al., 2015). Therefore, repeated
caffeine and ethanol co-consumption may produce more profound or widespread
neuroadaptation than exposure to either drug alone; one consequence of which could be
enhanced responsivity, or cross-sensitization, to stimulant drugs of abuse such as cocaine.

Conditioned Place Preference
Although cross-sensitization may reflect significant neuroadaptations as a
consequence of repeated drug exposure which may be associated with abuse potential,
studies suggest that sensitization is separable from the positive motivational effects or
rewarding value of a drug. Although the positive effects of drug consumption wane with
repeated usage in chronic drug abusers, the rewarding effects of a drug are likely important
in the earlier stages of drug use which may eventually influence later, problematic use
(Koob et al., 2004). This was nicely demonstrated by King and colleagues (2014) who
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showed that individuals that reported stronger positive responses (stimulation, liking) to an
acute ethanol challenge were more likely to meet use disorder criteria 6 years later.
The paradigm thought to probe drug ‘reward’ in rodents is conditioned place
preference (CPP). The fairly simple protocol for this assessment alternates administrations
of a drug (the unconditioned stimulus; UCS) paired with one context (conditioned stimulus
paired with drug; CS+) and administrations of the neutral drug vehicle with another,
distinct context (conditioned stimulus paired with the absence of drug; CS-). After a period
of repeated exposures to drug/vehicle and their respective contexts, animals are offered a
test trial wherein the neutral drug vehicle is administered and they are allowed to choose
between both contexts. Historically, drugs of abuse produce a significant preference for the
drug-paired context over the neutral context (Tzschentke, 2007). A major advantage of this
paradigm is that animals are presented this choice test in a drug-free state. This prevents
any interference of the drug’s pharmacological effects on performance and the animal
therefore must call upon its previous experience to decide whether it wants to approach or
avoid the drug-paired cue. As such, CPP is thought to reflect conditioned drug reward. CPP
is also sensitive to aversion, as animals can choose to spend significantly more time in the
context associated with the absence of the drug. Higher doses of drugs or withdrawal states
have been observed to produce place aversion (Risinger and Oakes, 1995; Stinus et al.,
2005). The ability of the CPP paradigm to assess behavior along a spectrum from aversion
to preference is considered a key strength. Although separate processes, the CPP paradigm
allows for easy collection of locomotor activity data during conditioning sessions, allowing
for the opportunity to compare locomotor sensitization and CPP locomotor data. Indeed,
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previous studies have observed cocaine locomotor sensitization during CPP training
(Seymour and Wagner, 2008; Shimosato and Ohkuma, 2000).
Both caffeine and ethanol produce CPP in rodents. Co-exposure may produce
stronger effects on mesolimbocortical reward circuitry which may influence sensitivity to
the rewarding effects of other drugs of abuse. Indeed, clinical evidence, as well as the
pharmacological profiles of ethanol and caffeine, suggest substantial potential for coexposure to enhance sensitivity to heavily dopamine-involved drugs of abuse such as
cocaine.

Caffeine and Ethanol: Adenosine, Dopamine, and Implications for Altered Cocaine
Sensitivity

Associations between Caffeine, Ethanol, and Cocaine Use: Clinical Observations
A strong association between cocaine and ethanol abuse has been well-documented,
with observations of ~60-84% of cocaine abusers also meeting diagnostic criteria for
ethanol use disorder during some point in their lives (Gorelick, 1992; Grant and Harford,
1990; Heil et al., 2001; Helzer and Pryzbeck, 1988). Interestingly, the reverse association
(effect of a history of ethanol exposure on cocaine sensitivity) does not appear to be as
strong. One report highlighted that only ~20-30% of ethanol-dependent patients also met
criteria for cocaine use disorder (Miller, 1991). In humans, a twin study by Kendler and
colleagues (2006) found that caffeine intake/dependence was significantly predictive of
cocaine abuse/dependence. Both energy drink/caffeine (Arria et al., 2010; Arria et al., 2011;
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Reissig et al., 2009) and ethanol (Kirby and Barry, 2012; McCabe et al., 2006; Welte and
Barnes, 1985) usage have been linked to polydrug use in humans. As such, co-exposure to
both caffeine and alcohol may enhance abuse potential for cocaine in an additive fashion.

Associations between Caffeine, Ethanol, and Cocaine Responsivity: Preclinical
Observations
Rodent studies have demonstrated that a history of cocaine exposure enhances the
acute locomotor stimulating effect of ethanol (Itzhak and Martin, 1999; Lessov and Phillips,
2003) and vice versa (Itzhak and Martin, 1999). In addition, naive rats selectively bred for
high ethanol consumption exhibited increased sensitivity to cocaine (Honkanen et al.,
1999), suggesting that this effect may have a genetic component. Rats with a chronic
caffeine consumption history have also been found to be more sensitive to the stimulant
effect of cocaine (Gasior et al., 2000; Jaszyna et al., 1998; O'Neill et al., 2015). These
findings, along with caffeine’s previously mentioned effects on the locomotor response of
mice to ethanol intoxication, raise questions about the potential for caffeine and ethanol
co-exposure to augment cross-sensitization to the locomotor stimulating effect of cocaine.
A history of caffeine consumption during adolescence has been shown to strengthen
later CPP for cocaine in adult rats (O'Neill et al., 2015). Furthermore, concurrent caffeine
exposure strengthens the development of CPP (Bedingfield et al., 1998). The effect of prior
alcohol consumption/exposure is more complex, however, with previous studies showing
both similar (Busse et al., 2005; Le Pen et al., 1998) and enhanced (Hutchison and Riley,
2012; Mateos-García et al., 2015; Stromberg and Mackler, 2005) cocaine CPP relative to
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rats and mice with no ethanol history. Along with the working hypothesis that binge
caffeine and ethanol co-consumption produces unique and potentially more profound
changes in the sensitivity to cocaine, a history of co-consumption may enhance the
rewarding properties of cocaine as assessed by CPP. Indeed, the pharmacological profiles
of caffeine and ethanol offer significant potential for altered sensitivity to the psychomotor
stimulating and/or rewarding effects of cocaine.

Adenosine and Adenosine Receptors
Caffeine is a non-selective competitive antagonist for adenosine receptors
(Fredholm et al., 1999) whereas ethanol indirectly increases extracellular adenosine levels
indirectly by inhibiting its transporter (Nagy et al., 1990) (Figure 1). Adenosine is a
purinergic nucleoside neuromodulator and its release occurs through nucleoside
transporters as a result of cell depolarization or elevated intracellular levels of adenosine
(Fredholm et al., 2005a). In the brain, this release is not restricted to neurons as microglia
and astrocytes can also release adenosine. Adenosine can also be synthesized
extracellularly from released adenosine triphosphate or cyclic adenosine monophosphate
(cAMP). For an in depth review of the adenosine system and brain function, see Fredholm
et al. (2005a).
Adenosine has a primary role as a homeostatic regulator of neural activity as well
as central and peripheral blood flow (Cunha, 2001). Throughout wakefulness, adenosine
accumulates in the brain as a byproduct of cellular metabolism and these levels are
normalized during sleep (Porkka-Heiskanen et al., 1997). Elevated adenosine levels and
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receptor activation has been linked to sedation and reduced vigilance in animals (Christie
et al., 2008; Mingote et al., 2008; Porkka-Heiskanen et al., 1997). As the main focus of this
project was neurobehavioral in nature, only the central effects of adenosine and its
receptors will be discussed further.
There are 4 known adenosine receptor subtypes: A1, A2A, A2B, and A3. By far, the
most common and well-studied subtypes in mammals are A1 (A1R) and A2A (A2AR). A1Rs
are located throughout the brain, with particularly high concentrations in the mammalian
cerebellum, hippocampus, and cerebral cortex (Fastbom et al., 1987; Goodman and Snyder,
1982). A2ARs are more localized, with the highest concentrations in the striatum (Rosin
et al., 1998), although they are also found at lower levels in the cortex (Svenningsson et al.,
1997) and hippocampus (Cunha et al., 1995; Cunha et al., 1994). Both A1Rs and A2ARs
are found pre and postsynaptically (Cunha, 2001; Rodrigues et al., 2005). A1Rs inhibit
whereas A2ARs stimulate adenylyl cyclase activity through coupling to Gi and Golf G
proteins in brain, respectively (Cunha, 2001). Stimulation of A1Rs decreases neuronal
excitability through downstream inhibition of calcium channels (MacDonald et al., 1986)
and activation of potassium channels (Trussell and Jackson, 1985). Activation of A2ARs
primarily acts to facilitate neurotransmitter release through elevated cAMP production
(Barraco et al., 1995; Shindou et al., 2002) and increased activity at these receptors has
even been linked to excitotoxicity (Popoli et al., 2003; Popoli et al., 2002).

Caffeine Pharmacology and its Behavioral Effects: Adenosine
Caffeine is classified as a competitive non-selective adenosine receptor antagonist.
Given the relationship between elevated levels of adenosine and sedation/reduced
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cognitive vigilance (Christie et al., 2008; Mingote et al., 2008; Porkka-Heiskanen et al.,
1997), caffeine’s psychostimulant properties are perhaps not surprisingly mediated through
the blockade of these receptors (Fredholm et al., 1999; Fredholm et al., 2005b). Preclinical
work has demonstrated specific roles for A1Rs and A2ARs in the neurobehavioral effects
of caffeine.
Surprisingly, a literature search yielded no published preclinical studies on the role
of A1Rs or A2ARs in caffeine intake. This is likely due to the previously demonstrated
difficulty of establishing voluntary, behaviorally-relevant consumption of a simple caffeine
and water solution in rodents (Heppner et al., 1986). As such, studies employing a caffeine
drinking paradigm typically opt for forced access by adding caffeine to the animal’s
standard drinking water (Hughes, 2011; Jaszyna et al., 1998; O'Neill et al., 2015) or food
deprivation (Heppner et al., 1986) to produce significant caffeine intake. In our mouse
model, however, male B6 mice will readily consume 10-15 mg/kg of caffeine in a short
period of 2 hours without fluid/food deprivation or sweetening (Fritz et al., 2014). In
addition, caffeine consumption is positively related to blood levels of caffeine and its
primary psychoactive metabolite, paraxanthine in this model (Figures 2 & 3). Furthermore,
this level of caffeine intake produces obvious behavioral motor stimulation (Fritz et al.,
2014), confirming that this level of intake is pharmacologically-relevant. This mouse
model is therefore likely the best available to address the role of adenosine receptor
subtypes in caffeine consumption in future studies.
Nevertheless, repeated caffeine exposure/consumption has been shown to increase
cortical A1R expression (Shi et al., 1994) and decrease striatal A2AR expression in rodents
(Singh et al., 2009). It has also recently been shown that separate groups of rats that
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consumed caffeine in adulthood or adolescence both exhibited increased A1R levels in the
nucleus accumbens. However, only rats that consumed caffeine in adolescence displayed
a decrease in accumbal A2AR levels (O'Neill et al., 2015). Therefore across key brain
regions involved in the response to drugs of abuse, caffeine exposure appears to increase
A1R expression and decrease A2AR expression.
The caffeine research field generally agrees that the psychostimulant properties of
caffeine are largely due to antagonism of the A2AR. However, it has been hypothesized
that A1 and A2AR heteromers may be the primary mediators of these effects (Ferre et al.,
2008). CPP studies have found specific roles for these receptor subtypes in the conditioned
rewarding effects of caffeine. Blockade of the A2AR, but not A1R appears to be an
important mechanism in the development of caffeine CPP (Brockwell and Beninger, 1996;
Hsu et al., 2009).
Knockout studies in mice have demonstrated that caffeine produces locomotor
stimulation and wakefulness in A1R knockout mice, but not A2AR knockout mice (Huang
et al., 2005; Yacoubi et al., 2000). Furthermore, A2AR antagonists (Fritz and Boehm II,
2015; Müller et al., 1998; Nagel et al., 2003), but not A1R antagonists (Brockwell and
Beninger, 1996; Griebel et al., 1991), robustly stimulate locomotor activity in rodents.
Locomotor sensitization to caffeine is also mediated by blockade of the A2AR (Hsu et al.,
2009). A1Rs have been associated with the cognitive-enhancing effects of caffeine as
antagonism of these receptors can increase acetylcholine release in the hippocampus
(Carter et al., 1995) and cerebral cortex (Kurokawa et al., 1996; Materi et al., 2000). Given
the ability of caffeine to improve performance on working memory tasks and maze learning
(Angelucci et al., 2002; Castellano, 1976; Prediger et al., 2005), antagonism of the A1R
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has been proposed to mediate this effect. In addition, A1R (Karcz-Kubicha et al., 2003),
but not A2AR (Halldner et al., 2004), antagonism is an important mechanism for the
development of caffeine tolerance. Both A1Rs and A2ARs, however, have been linked to
neuroprotective effects in Alzheimer’s and Parkinson’s disease animal models with chronic
treatment decreasing neuronal markers of degeneration and improving performance on
cognitive tasks (Dall'lgna et al., 2003; Rodrigues et al., 2015; Rosso et al., 2008).
Collectively, the work reviewed above indicates that the majority of evidence
points to the A2AR as the primary target through which caffeine’s psychostimulant effects
are achieved. However, the A1R is an important mediator of caffeine-enhanced cognition
as well as tolerance development. Given that A2ARs, but not A1Rs, are primarily involved
in the locomotor and rewarding effects of caffeine, these receptors may also be the likely
mechanism through which prior caffeine intake could influence cocaine sensitivity in the
present study.

Ethanol Pharmacology and its Behavioral Effects: Adenosine
Ethanol promotes adenosine signaling in an indirect manner by inhibiting its
transporter, ENT1 (Allen-Gipson et al., 2009; Nagy et al., 1990), thus allowing a larger
amount of adenosine to accumulate extracellularly and interact with receptors. This effect
was linked to ethanol-induced sedation and motor incoordination as mice lacking the
adenosine transporter ENT1 exhibit significantly reduced sensitivity to these effects (Choi
et al., 2004). This is not surprising considering the previously mentioned sedative effects
of adenosine signaling.
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Voluntary drinking and self-administration studies have primarily found that the
A2AR, but not the A1AR is an important mediator of ethanol seeking and consumption.
A2AR antagonists have been observed to both increase (Arolfo et al., 2004; Micioni Di
Bonaventura et al., 2011) and decrease (Adams et al., 2008; Thorsell et al., 2007) ethanol
consumption and seeking whereas agonists have only been observed to decrease these
behaviors (Houchi et al., 2013; Houchi et al., 2008; Micioni Di Bonaventura et al., 2011).
A recent study also found that a reduction in A2AR activity in the dorsomedial striatum, a
region mediating goal-directed behavior, significantly increased ethanol intake in an
operant paradigm in mice (Nam et al., 2013). All of these studies either did not assess the
effects of A1R-selective drugs or found that they had no effect. However, a recent study in
our lab employing the DID model found that A1R antagonism significantly reduced bingelike ethanol consumption whereas the A2AR antagonism had no effect (Fritz and Boehm
II, 2015). We proposed that this apparent discordance may have been due to differences in
the duration of alcohol access. Our study involved 7 days of ethanol drinking via DID
whereas these earlier studies employed drinking paradigms lasting weeks. As the A1R is
an important target for the development of tolerance to ethanol (Batista et al., 2005), we
proposed that the lack of effect of A1R manipulation in the more protracted drinking
studies may have reflected this adaptive mechanism.
Repeated ethanol exposure does not appear to have an effect on the expression or
binding capability of A2ARs receptors (Daly et al., 1994; Jarvis and Becker, 1998).
However, chronic ethanol consumption significantly increased cortical A1R density in
mice (Daly et al., 1994). Repeated ethanol vapor exposure was also observed to increase
A1R levels, however, the number of A1R binding sites detected with radioligand labeling
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was unaltered (Jarvis and Becker, 1998). An enhancement of A1R binding was observed
in cerebellum following chronic ethanol exposure, however, this effect may persist for as
little as 3 days (Concas et al., 1996). These findings suggest that any significant adaptation
of adenosine receptors produced by ethanol exposure likely involve A1Rs, but not A2ARs.
Nevertheless, both receptor subtypes mediate different responses to acute ethanol
intoxication.
The A1R appears to be an important target for ethanol-induced ataxia. Rats
pretreated with an A1R antagonist exhibit significantly reduced ataxia following an ethanol
injection on the rotorod apparatus (Barwick and Dar, 1998; Connole et al., 2004).
Furthermore, antagonism of the A1R, but not A2AR, attenuates the development of
tolerance to ethanol’s ataxic effects (Batista et al., 2005), suggesting that the A1R is an
important mediator of ethanol-induced neuroadaptation. Finally, pretreatments with an
A1R antagonist significantly blunted the ability of ethanol to increase the time mice spent
on the open arms of the elevated plus maze apparatus (Prediger et al., 2004), suggesting an
important role for the A1R in ethanol’s anxiolytic effects.
A2ARs on the other hand, are important targets for sedation induced by high doses
of ethanol (≥ 3 g/kg). Pretreatment with an A2AR antagonist significantly reduces the
duration of the ethanol-induced loss of righting reflex (El Yacoubi et al., 2003), a measure
of the sedative hypnotic effects of ethanol. Furthermore, A2AR knockout mice also
demonstrate a significantly shorter loss of the righting reflex (Naassila et al., 2002) and
heightened sensitivity to lower doses of ethanol (0.5-2.0 g/kg) as evidenced by enhanced
ethanol-induced locomotor stimulation and anxiolysis (Houchi et al., 2008). Finally, A2AR
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knockout mice also exhibit enhanced CPP for these lower doses of ethanol (Houchi et al.,
2008).
Collectively, these findings suggest a complicated role for adenosine signaling in
ethanol-related behaviors. Ethanol consumption and its conditioned rewarding effects
appear to be primarily influenced by the A2AR, however the A1R has been demonstrated
to be involved in binge-like consumption in the DID paradigm. The A1R is an important
regulator of motor incoordination induced by ethanol whereas the A2AR mediates the
sedative hypnotic effects of high doses of ethanol.

Dopamine and Dopamine Receptors
DA is the most well-known neurotransmitter system in substance abuse research, a
classical catecholamine neurotransmitter that is initially synthesized from tyrosine in the
synaptic terminal by the enzyme tyrosine hydroxylase (Missale et al., 1998). DA cell
bodies are located in the ventral midbrain and substantia nigra with projections to the
frontal and limbic cortex, hippocampus, amygdala, and striatum. Studies have long
demonstrated a strong role for DA in motivated behavior (Nunes et al., 2013; Phillips et
al., 2003; Wilson et al., 1995). Furthermore, increased DA signaling has behaviorallyreinforcing effects associated with addiction-like behavior (Pascoli et al., 2015). The DA
literature is vast, therefore the introduction below is only a brief overview. The interested
reader is referred to a number of reviews on DA and its role in substance abuse (Everitt
and Robbins, 2005; Gorwood et al., 2012; Le Foll et al., 2009; Missale et al., 1998; Nutt et
al., 2015).
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There are 5 DA receptor subtypes (D1, D2, D3, D4, D5) with the D1 and D2 subtypes
being the most pervasive in brain and consequently the most frequently studied (Le Foll et
al., 2009). These subtypes are often separated into two classes: D1-like receptors (D1 and
D5; D1Rs) and D2-like receptors (D2, D3, D4; D2Rs). D1Rs are located throughout the
mesolimbocortical and nigrostriatal pathways. They are coupled to Gs proteins, thus
stimulating cAMP production via adenylyl cyclase, and act to increase neuronal
excitability through downstream second messenger signaling effects (e.g. release of
internal calcium stores and inhibition of potassium channels) (Missale et al., 1998). D1Rs
are located both pre and postsynaptically (Levey et al., 1993). Stimulation of D1Rs within
the ventral tegmental area has been demonstrated to increase neurotransmitter release
(Cameron and Williams, 1993; Kalivas and Duffy, 1995), however, activation of D1Rs has
also been observed to attenuate both excitatory and inhibitory postsynaptic potentials in
the nucleus accumbens (Pennartz et al., 1992). D1R signaling therefore does not appear to
purely result in an increase in neurotransmitter release.
D2Rs are also found throughout the mesolimbocortical and nigrostriatal pathways,
although they are highly concentrated on DA cell bodies in the ventral tegmental area and
substantia nigra (Missale et al., 1998). D2Rs are coupled to Gi/olf G-proteins and their
activation inhibits adenylyl cyclase production of cAMP, and ultimately, inhibition of the
cell. D2Rs can be found both pre and postsynaptically and interestingly, presynaptic D2
receptors serve as autoreceptors, acting to decrease further DA release when activated by
higher levels of synaptic DA (Ford, 2014). D2R activation increases outward potassium
currents, resulting in hyperpolarization of the membrane potential (Williams et al., 1989).
Furthermore, stimulation of D2Rs has been shown to inhibit calcium channels (Lledo et al.,
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1992), ultimately decreasing the likelihood of neurotransmitter release. In summary, D1Rs
and D2Rs regulate neuronal excitability and neurotransmitter release in an apparently
opposing manner in key brain regions associated with substance use and abuse.

Caffeine Pharmacology and its Behavioral Effects: Dopamine
Caffeine consumption/exposure has been observed to enhance D2R, but not D1R,
expression or function in the nucleus accumbens of rats (O'Neill et al., 2015; Simola et al.,
2008). Chronic caffeine treatment also increases striatal levels of DA transporter (DAT)
expression in a limited manner (Singh et al., 2009). However, caffeine consumption
throughout adolescence produced a roughly 30% increase in DAT levels in the nucleus
accumbens of rats (O'Neill et al., 2015).
Like virtually all classes of drugs of abuse (Di Chiara and Imperato, 1988), caffeine
acutely increases DA levels in the nucleus accumbens (Solinas et al., 2002) and this effect
has been linked to its psychostimulant properties (Ferré, 2016). However, this DAergic
response is likely mediated by the previously mentioned functional interaction between
adenosine and DA receptors (Ferré, 2016; Fuxe et al., 2005). Nevertheless, caffeine’s
psychostimulant effects are influenced by both D1Rs and D2Rs. Caffeine locomotor
stimulation in rats is blocked by co-administration of D1R or D2R antagonists (Garrett and
Holtzman, 1994). Furthermore, rats exhibiting tolerance to caffeine locomotor stimulation
demonstrate cross-tolerance to the stimulant effects D1R and D2R agonists (Garrett and
Holtzman, 1994). Repeated caffeine exposure has also been observed to produce crosssensitization to potent DA-enhancing psychostimulants, such as amphetamine and cocaine
(Misra et al., 1986; O'Neill et al., 2015; Schechter, 1977), as well as the D1R agonist SKF

28
77434 (Cauli and Morelli, 2002) and the D2R agonist quinpirole (Cauli and Morelli, 2002;
O'Neill et al., 2015; Pollack et al., 2010).
Collectively, the findings reviewed above indicate that repeated caffeine exposure
can induce substantial alterations in DA-signaling-related proteins in key brain areas
associated with substance use/abuse. Furthermore, repeated caffeine exposure engages
important neuroadaptive processes associated with drug abuse (tolerance and sensitization)
that are influenced by DAergic processes.

Ethanol Pharmacology and its Behavioral Effects: Dopamine
Ethanol also induces DA release in the nucleus accumbens (Imperato and Di Chiara,
1986; Weiss et al., 1993; Yoshimoto et al., 1992), although more recent research suggests
this observation may be related to ethanol cues, themselves (Doyon et al., 2003). Ethanol
consumption/exposure produces complicated and inconsistent changes in D1R and D2R
expression in rodent models. Ethanol exposure has been observed to both increase
(Lograno et al., 1993; Tajuddin and Druse, 1996) and decrease (Lucchi et al., 1988) the
density and binding capacity of striatal D1Rs and D2Rs. However, another study found no
effect of 5 weeks of ethanol exposure on D1R or D2R labeling in the striatum or frontal
cortex of rats (Hietala et al., 1990). Ethanol consumption has also been associated with
increased striatal and accumbal mRNA expression of D2Rs, but not D1Rs, after 5 weeks
of 10% ethanol drinking in rats (Kim et al., 1997). Alterations in DA receptor binding
following ethanol consumption has also been evaluated in rats selectively bred for high
alcohol preference. Previous ethanol intake increased D1R binding in the accumbens core
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and amygdala and increased D2R binding in the accumbens core and shell as well as the
striatum of alcohol preferring P rats (Sari et al., 2006).
Knockout studies in mice have implicated important roles for both D1Rs (ElGhundi et al., 1998) and D2Rs (Phillips et al., 1998) in 2-bottle choice ethanol consumption
with the knockout mice drinking significantly less ethanol than their wildtype counterparts.
Pharmacological studies have also demonstrated significant contributions of both D1Rs
and D2Rs in ethanol consumption, although the directions of these findings are not
consistent. Both D1R agonists and antagonists have been observed to decrease ethanol
intake in rats and mice (Cohen et al., 1999; Dyr et al., 1993; Ng and George, 1994; Silvestre
et al., 1996). The same is true for D2R agonists and antagonists (Dyr et al., 1993; Pfeffer
and Samson, 1986). These observations suggest that DA receptor activation indeed plays
a role in ethanol intake, as antagonists may blunt the receptor level effects of the dopamine
response to ethanol consumption whereas agonists may ‘substitute’ for ethanol’s effects.
Collectively, these results indicate that DA signaling is highly important in ethanol intake,
with an optimal level of DA receptor activation driving consumption.
Ethanol-induced locomotor stimulation (Cohen et al., 1997; Kong et al., 2010;
Liljequist et al., 1981) and sensitization (Phillips et al., 1997) have both been tied to
enhanced DA signaling in rodents. Viral vector knockdown of D1Rs in the nucleus
accumbens significantly reduced ethanol intake as well as ethanol locomotor sensitization
and CPP acquisition in mice (Bahi and Dreyer, 2012). D2R knockout mice bred on a B6
background demonstrate enhanced ethanol locomotor stimulation and sensitization
(Palmer et al., 2003). Furthermore, these sensitized mice did not display reduced ethanol
intake as previously observed in D2R knockouts (Phillips et al., 1998), suggesting
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sensitization promoted ethanol consumption. D2R knockout mice also exhibit blunted CPP
for ethanol (Cunningham et al., 2000), however, a more recent study from the same lab
indicated that pharmacological antagonism of D1Rs, but not D2Rs, in the nucleus
accumbens blunted the acquisition of ethanol CPP (Young et al., 2014). DA signaling does
not appear to influence tolerance to adverse effects of ethanol intoxication. Rats depleted
of brain dopamine via intraventricular infusion of 6-hydroxydopamine displayed similar
tolerance to motor-impairing and hypothermic effects of ethanol following ~4 weeks of
exposure (Lê et al., 1981).
Although the literature on dopamine’s involvement in ethanol-related behavior is
expansive and this brief overview is certainly not exhaustive, the above studies clearly
demonstrate a significant role for DA in ethanol consumption and reward. A history of
ethanol intake can also significantly alter the expression of dopamine receptor subtypes in
key brain regions associated with substance abuse. Finally, both classes of DA receptors
have the capacity to influence the neurobehavioral adaptive sensitization response.

Adenosine and Dopamine Receptor Functional Interactions
The adenosine and dopamine systems are closely intertwined with A1Rs often colocalizing with D1Rs and A2ARs localizing with D2Rs (see Fredholm, et al. 1999; 2005
for reviews). Furthermore, these adenosine receptors can form functional heteromers with
their respective DA receptor (Ferre et al., 2008). Presynaptic A1R activation has been
demonstrated to shunt dopamine release and postsynaptic A1R activation antagonistically
interacts with coupled D1Rs to decrease binding availability as well as the coupling ability
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of Gs proteins. Activation of adenosine A2ARs has also been shown to reduce the binding
availability of D2Rs. The functional relationship between adenosine receptor activation
and signaling at coupled DA receptors is therefore antagonistic. Concomitant caffeine may
suppress the signaling capability of enhanced adenosinergic tone induced by ethanol
(Figure 1), potentially relieving inhibition of elevated dopamine signaling induced by both
compounds. Therefore, repeated exposure to their combination may produce more
pronounced and diverse alterations in neurobiology/neurochemistry than exposure to either
drug alone. Indeed, a history of caffeinated ethanol consumption in female alcoholpreferring P rats was associated with increased basal levels of extracellular DA in the
medial prefrontal cortex (Franklin, 2009). Therefore, alterations in the mesolimbocortical
DA system produced by a history of caffeine and ethanol co-consumption may have
significant implications for an individual’s sensitivity to the heavily DA-involved effects
of psychostimulant drugs of abuse, such as cocaine.

Cocaine Pharmacology and its Behavioral Effects: Adenosine
Although research in the last 20 years suggests the picture is more complex than
initially thought (Rocha et al., 1998; Uhl et al., 2001), cocaine’s primary mechanism of
action is still considered to be dopamine transporter (DAT) blockade (Sulzer, 2011);
effectively prolonging the presence of endogenously released dopamine in the synaptic
cleft. Given the previously described functional relationship between adenosine and DA
signaling, it is not surprising that a role for adenosine receptors has been implicated in
cocaine-related behaviors.
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Repeated cocaine exposure has been observed to increase A1R expression levels
within the nucleus accumbens (Toda et al., 2002). Later work demonstrated discordance
between this upregulation and the functional nature of these A1Rs. Even though repeated
cocaine did produce an increase in A1R expression level, a reduction in receptor binding
was actually observed (Toda et al., 2003), suggesting an internalization of receptors. A
history of cocaine self-administration was also shown to increase A2AR levels in the
nucleus accumbens (Marcellino et al., 2007), with later work suggesting that repeated
cocaine exposure may encourage the dissociation of functional heteromers with D2Rs
(Marcellino et al., 2010).
The A1R has been demonstrated to regulate cocaine seeking as pretreatment with
an A1R antagonist attenuates extinction (Kuzmin et al., 1999). Both caffeine (non-selective
adenosine receptor antagonist) and an A1R/A2AR selective antagonist have been shown
to effectively reinstate cocaine seeking after the extinction of responding in non-human
primates (Weerts and Griffiths, 2003), and drug discrimination work has suggested that the
blockade of these receptors may mimic some of cocaine’s discriminative stimulus effects
(Justinova et al., 2003). A2AR knockout mice exhibit a significant attenuation of cocaine
self-administration acquisition (Soria et al., 2005), suggesting that the A2AR is also an
important regulator in the establishment of problematic cocaine consumption. Furthermore,
pretreatment with an A2AR agonist effectively attenuates cocaine self-administration and
reinstatement in rats and non-human primates (Bachtell and Self, 2009; Knapp et al., 2001;
Weerts and Griffiths, 2003). These findings were more recently extended to
microinjections within the rat nucleus accumbens (O'Neill et al., 2012), although it was
also found that intra-accumbens A2AR antagonism increased cocaine seeking. It should be
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noted, however, that adenosine receptor agonists can have potent motor-impairing effects
which may interfere with the assessment of these behaviors (Knapp et al., 2001).
A2AR knockout mice demonstrate cocaine locomotor stimulation and CPP
equivalent to that of wildtype counterparts (Soria et al., 2005). Activation of the A2AR,
however, impairs the development and expression of cocaine sensitization (Filip et al.,
2006). Conversely, A2AR antagonism enhances cocaine locomotor sensitization (Filip et
al., 2006). Within the nucleus accumbens, pharmacological activation of both A1Rs and
A2ARs inhibits the expression of cocaine locomotor sensitization in rats (Hobson et al.,
2012). Both receptor subtypes also influence cocaine CPP, with agonists and antagonists
both blunting the expression and induction of CPP in rats (Poleszak and Malec, 2002).
As with caffeine and ethanol, adenosine signaling also has a significant capacity to
influence cocaine self-administration, stimulation/sensitization, and reward. These effects
are likely influenced to some degree by the regulatory role of adenosine signaling on DA
transmission. As with all psychostimulant drugs, DA signaling is heavily involved in
cocaine’s neurobehavioral effects which are briefly reviewed below.

Cocaine Pharmacology and its Behavioral Effects: Dopamine
Cocaine acutely increases DA in the nucleus accumbens (Hernandez and Hoebel,
1988) and repeated administration has been observed to sensitize this effect (Kalivas and
Stewart, 1991). Repeated cocaine exposure alters functional D1R and D2R expression in
key brain regions. Both D1R and D2R binding sites are significantly reduced following
repeated cocaine in rat striatum and nucleus accumbens (Kleven et al., 1990; Tsukada et
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al., 1996). Although these changes were persistent in the striatum, they were no longer
apparent in the nucleus accumbens 2 weeks following the cessation of cocaine treatment
(Kleven et al., 1990). In non-human primates, however, repeated cocaine increased D1R
binding and decreased D2R binding in the striatum (Nader et al., 2002). Three weeks of
cocaine self-administration has, however, been observed to produce a persistent decrease
in D2R levels, but no change in D1R levels, in the medial prefrontal cortex of rats (Briand
et al., 2008). Cocaine exposure has also generally been demonstrated to increase DAT
expression (Kahlig and Galli, 2003). These findings suggest that repeated cocaine exposure
produces significant adaptations in both functional D1Rs and D2Rs as well as DAT,
although the persistent nature of these changes may be brain region-specific.
In operant paradigms, D1Rs and D2Rs regulate cocaine self-administration and
seeking. Antagonism of D1Rs and D2Rs significantly increases cocaine self-administration
in rats and non-human primates (Bergman et al., 1990; Caine et al., 2002; Koob et al.,
1987). These findings have been replicated via local administration in the nucleus
accumbens of rats (Bari and Pierce, 2005). Interestingly, D1R knockout mice will not
reliably self-administer cocaine (Caine et al., 2007) whereas D2R knockout mice selfadminister significantly more cocaine than their wildtype counterparts (Caine et al., 2002).
For the regulation of cocaine relapse-like behavior, these receptor subtypes have opposite
effects with the administration D1R agonists blocking (Self et al., 1996), and D2R agonists
enhancing (De Vries et al., 1999; Self et al., 1996; Wise et al.) the reinstatement of
responding for cocaine.
DA signaling appears to be crucial for the induction of cocaine locomotor
sensitization as co-administration of D1R and D2R antagonists significantly reduces the
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development of cocaine sensitization (Fontana et al., 1993). Furthermore, D1R knockout
mice exhibit attenuated locomotor sensitization to repeated cocaine (Xu et al., 2000).
Activation of D2Rs has also been demonstrated to play an important role in both cocaine
locomotor stimulation and sensitization. Microinjections of a D2R agonist, but not a D1R
agonist, directly into the medial prefrontal cortex attenuated both the development and
expression of cocaine sensitization (Beyer and Steketee, 2002). In addition, this cortical
microinjection of a D2R agonist significantly reduced cocaine-sensitized DA release in the
nucleus accumbens. Furthermore, the increased locomotor stimulant response to and
enhanced CPP for cocaine observed in rats that had previously consumed caffeine as
adolescents was associated with an increased stimulant response to an injection of a D2R
agonist as well as elevated D2R levels in the nucleus accumbens (O'Neill et al., 2015). D2R
knockout mice also exhibit a decreased locomotor stimulant response (Welter et al., 2007).
D1R knockout mice exhibit unaltered cocaine CPP (Miner et al., 1995). However,
CPP studies in intact animals have consistently demonstrated that D1R, but not D2R,
signaling is crucial for the expression of cocaine CPP (Bardo and Bevins, 2000). These
results suggest that although the D1R is a primary target for cocaine CPP, other
neurotransmitter systems or receptors can be involved in the development of cocaine CPP.
Collectively, these results demonstrate that cocaine self-administration and seeking,
locomotor stimulation/sensitization, and conditioned reward are all influenced by DA
receptor signaling. Both D1Rs and D2Rs appear to influence each of these phenotypes in
some way. Given the extent of DA and adenosine involvement in cocaine-related behaviors
as well as those associated with ethanol and caffeine, the substantial overlap in the systems
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involved raises the possibility that co-exposure of caffeine and ethanol may enhance an
individual’s sensitivity to cocaine.

Pilot Study
To probe for whether caffeine and ethanol co-exposure altered cocaine sensitivity
in the established caffeine and ethanol co-consumption model previously described, a pilot
study was conducted. Adult male B6 mice were given access to water, caffeine (0.03%
w/v), ethanol (20% v/v), or a combined ethanol caffeine solution via 2hr DID for 2 weeks.
Mice were then injected with saline (i.p.) each of the following 2 days and baseline
locomotor activity was recorded in 15 minute sessions. The next day, mice received a 10
mg/kg (i.p.) cocaine challenge injection or saline. This preliminary study found a statistical
trend (p = 0.07) towards a particularly robust stimulant response to cocaine in mice that
had previously consumed the caffeinated ethanol solution (Figure 4), offering preliminary
evidence in the direction of the hypothesis that caffeinated ethanol exposure may increase
cocaine sensitivity.

Study Rationale
Heavy caffeine and ethanol use have been associated with polydrug abuse,
including cocaine, in the clinical literature (Kendler et al., 2006; Kirby and Barry, 2012).
With the rise of energy drinks, individuals are now co-consuming caffeine and ethanol at
unprecedented levels. The protracted consequences of such consumption are poorly

37
understood and given these associative risks, a history of co-consumption may increase the
abuse potential for drugs of abuse like cocaine.
Preclinical work in rodents has demonstrated that caffeine and ethanol co-exposure
can produce additive stimulant effects (Ferrario et al., 2005; Hilbert et al., 2013; Kuribara
et al., 1992; May et al., 2015) and augment the locomotor sensitization response to repeated
administration (May et al., 2015). Furthermore, 14 days of prior binge-like caffeine and
ethanol co-consumption produced elevated basal extracellular dopamine levels in the
medial prefrontal cortex of female alcohol-preferring P rats (Franklin, 2009). This suggests
a potentially enhanced DAergic tone produced by caffeine and ethanol co-consumption
that may influence sensitivity to heavily DA-involved psychostimulant drugs of abuse,
such as cocaine.
Along these lines, both prior caffeine and ethanol exposure alone can enhance
sensitivity to the psychomotor stimulating and conditioned rewarding effects of cocaine in
preclinical animal models (Bedingfield et al., 1998; Hutchison and Riley, 2012; MateosGarcía et al., 2015; O'Neill et al., 2015). This may be due, in part, to aforementioned
alterations in DA signaling-related proteins by caffeine and ethanol and/or alterations of
adenosine receptors which regulate DA signaling. Considering the literature reviewed
above, combined caffeine and ethanol exposure may have the capacity to additively
enhance cocaine sensitivity. Locomotor sensitization and CPP are two of the most widely
used and well defined phenotypes in preclinical substance abuse research. As such, both
were employed in the current study to gain a multifaceted understanding of how cocaine
sensitivity may be altered by repeated binge-like caffeine and ethanol co-consumption.
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MATERIALS AND METHODS

Animals
Adult (postnatal day 56 ± 3) male B6 mice were ordered from the Jackson
Laboratory (Bar Harbor, ME) and singly housed upon arrival. Lighting was maintained on
a 12-hour reverse light-dark cycle with lights off at 0800 for the work conducted in
Experiment 1 and lights off at 0600 for the work conducted in Experiment 2. The
temperature and humidity of the room were held constant near 20°C and 50%, respectively.
Food and water were available ad libitum, except during the 2hr drinking access periods
where mice had their water bottles replaced with a sipper tube containing tap water (W),
20% (v/v) ethanol in tap water (E), 0.03% (w/v) caffeine in tap water (C), or a combined
20% ethanol and 0.03% caffeine solution (EC). Mice were allowed 10-14 days to acclimate
to the colony room and light cycle prior to the initiation of testing. All experiments were
performed under a protocol approved by the IUPUI Institutional Animal Care and Use
Committee.

Drugs and Drinking Solutions
The ethanol solution was made by diluting 190 proof ethanol (Pharmco Inc.,
Brookfield, CT) in tap water. Caffeine was obtained from Sigma Aldrich (St. Louis, MO)
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and was dissolved in either tap water or the ethanol solution. Cocaine hydrochloride was
also purchased from Sigma Aldrich (St. Louis, MO) and was diluted in 0.9% physiological
saline.

Drinking-in-the-Dark
Beginning 3 hours into the animals’ dark cycle, mice had their standard glass water
bottles removed and replaced with specially-made 10 ml drinking tubes (a picture of the
DID setup can be seen in Figure 5). These tubes consisted of a 10 ml plastic serological
pipette fitted with a stainless steel double ball bearing sipper. A silicone stopper was fitted
to the open end after filling. Tube volumes were read immediately prior to placing the tube
on an animal’s cage at eye level and the tube was secured to the cage using a metal binder
clip. These tubes remained on the cage for the 2hr limited access period and volume
readings were again taken immediately after this time elapsed. All volume readings were
taken at the 0.01 ml level of measurement. During this 2hr period, the only fluid to which
mice had access was their designated test fluid. After the DID session, the standard home
cage water bottles were returned. Empty cages were also fitted with tubes containing tap
water or the ethanol solution to estimate the relative degree to which each fluid leaked from
tubes during the 2hr DID period. Consumption volumes were corrected by the average leak
for water (caffeine or water alone) or ethanol (ethanol or ethanol + caffeine) solutions
throughout each experiment.
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Activity Monitoring
For both experiments, the locomotor activity/position of mice was monitored by 8
AccuScan VersaMax activity monitors (Omnitech Electronics Inc., Columbus, OH)
controlled by a Dell computer. These monitors identify the animal’s position via the
disruption of intersecting photocell beams spaced evenly along the 40 × 40 cm walls of the
testing field. In Experiment 1, mice were contained in a Plexiglas box measuring 40×40×31
cm (l×w×h) and fitted with a lid during testing (Figure 6). In Experiment 2, mice were
contained in a smaller Plexiglas box centered in the apparatus measuring 25×14×15 cm
(Figure 7). All of this testing equipment was housed within a light and sound attenuating
chamber measuring 53×58×43 cm, containing a fan providing both ventilation and ‘white
noise’. At the conclusion of testing, activity data was translated to the position and/or total
distance traveled by each mouse (in cm) in each session by the VersaMax software.

Experiment 1: Locomotor Sensitization
The objective of Experiment 1 was to evaluate the effects of various caffeine and
ethanol drinking histories on the locomotor stimulation/sensitization response to cocaine
(see Figure 8 for a timeline of the procedure used in Experiment 1). Mice (N = 275)
underwent a 14-day DID procedure where they received daily 2hr access to W, E, C, or EC
(beginning at 1100). As DID is a self-administration paradigm and dosing varies for
individual animals, it was anticipated that some mice may not readily consume ethanol,
caffeine, or their combination. In order to properly address the hypothesis concerning
‘binge’ consumption without employing a stressful blood sample analysis, a strategy to
extrapolate BEC values on the basis of fluid intake data was adopted. In our lab’s
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experience as well as others’ (Rhodes et al., 2005), ethanol consumption in DID with male
B6 mice is very tightly correlated with the attained BEC. Therefore, the BEC achieved via
DID ethanol intake can be comfortably predicted. Figure 9 depicts ethanol intake and BEC
data following DID on day 14 from a prior study in our lab (Fritz et al., 2014). As can be
seen, ethanol intake is highly predictive of BEC. A binge level BEC in this paradigm is
generally considered to be ≥ 80 mg/dl and the data in Figure 9 suggest that consumption of
≥ 3 g/kg ethanol will produce BECs of this magnitude. As such, it was planned that mice
that drank less than 3 g/kg ethanol per day (19 ml/kg total fluid), on average, would be
excluded from the remainder of the experiment. This criterion was applied to both E and
EC groups. To also keep consistency with caffeine intake, this fluid volume criterion (19
ml/kg) was also applied to the C group which translates to a minimum average daily DID
caffeine intake of 5.7 mg/kg.
The 11-day cocaine sensitization protocol was adopted from Lessov and Phillips
(2003) and was initiated on day 15. Each testing day, mice were allowed at least 1hr to
habituate to the activity monitor room prior to testing. All locomotor testing occurred under
red light. On days 15-16, mice received an injection of 0.9% physiological saline (i.p.)
beginning at 1100 and were immediately placed into the Accuscan VersaMax activity
monitors for 15 minutes. The purpose of these first 2 days is to habituate the animals to the
apparatus and injection procedure. Starting on day 17, mice were subjected to injections of
cocaine (5 or 10 mg/kg; i.p.) or saline every other day, with 15 minute activity monitoring
until day 25. The baseline activity measures on days 15-16 were used to counterbalance
mice for dose and designation to one of three conditions for the remainder of the
experiment: cocaine-naïve (CN), acute cocaine (AC), or repeated cocaine (RC). CN mice
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received saline throughout the entire experiment, serving as a control for repeated injection
stress on basal activity. AC mice received saline until the final day of the sensitization
protocol whereupon they received their first and only dose of cocaine. This condition
assesses any effect repeated injection stress may have on responsivity to cocaine; an
important control considering that stressors have been shown to sensitize responses to
drugs of abuse (Kalivas and Stewart, 1991). The RC group received cocaine on each
locomotor assessment day for the remainder of the experiment. Sensitization is
characterized in two different ways in this design: 1) a significant increase in activity from
the first injection of drug (day 17) to the final injection in RC groups (day 25), indicating
the classically-defined progressive increase in response to drug and 2) significantly greater
activity in RC mice relative to AC mice, which considers the potential for the repeated
injection procedure to influence the locomotor response to the drug. Both characterizations
offer important information for the interpretation of sensitization data and together, provide
the most complete description of the data.

Experiment 2: Conditioned Place Preference
The objective of Experiment 2 was to determine whether various caffeine/ethanol
drinking histories differentially influence the conditioned rewarding effects of cocaine as
assessed by the CPP paradigm (for a timeline of the procedure used in Experiment 2, see
Figure 10). As in Experiment 1, mice (N = 240) first underwent an identical 14-day DID
procedure following acclimation to the colony room. The same drinking criterion (≥ 3 g/kg
ethanol or 5.7 mg/kg caffeine average daily intake) was implemented for Experiment 2.
The CPP protocol commenced on day 15 and mice were moved into the activity monitor
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room at least 1hr prior to testing in order to habituate them to the room each day. All testing
occurred under red light. On day 15, mice received saline injections starting at 0900 and
were immediately placed onto a neutral floor texture (paper) in the place conditioning box
for 15 minutes in order to habituate the animals to the apparatus and injection procedure.
The activity chambers determined the location of the mouse in the chamber over the course
of each session and also recorded general locomotor activity. For conditioning sessions,
two different tactile cues were used: a metal floor with punched holes or a floor made of a
grid of small metal rods (Figure 11). These exact floor textures have been used extensively
in place conditioning with mice since animals consistently show no baseline preference for
one texture over the other (Cunningham et al., 2006). Mice were counterbalanced for dose,
drug-paired floor, and order of drug exposure (odd or even days) on the basis of their
caffeine/ethanol intake and baseline locomotor activity on day 15. Starting on day 16, mice
received daily alternating systemic injections of cocaine (1 or 5 mg/kg; i.p.) and saline or
saline throughout (naïve controls) and were placed into the monitors for 15 minute
conditioning sessions. The low dose was chosen since it has been shown previously to
induce mild CPP in male B6 mice and may enhance the ability to detect substantial
increases in sensitivity to cocaine reward (Cunningham et al., 1999). The 5 mg/kg dose
was chosen because it parallels the low dose in Experiment 1, thereby offering a point of
consistency in collective interpretation. These sessions alternated drug and vehicle over the
course of 8 days so that a total of 4 drug and 4 saline injections were given. In the
conditioning literature, each pair of saline and drug exposures is referred to as a ‘trial’ (i.e.
days 16-17 constitute ‘trial 1’). The first place preference test occurred on day 24 wherein
all mice were injected with saline and offered access to both floor textures (Figure 7
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illustrates an example of a CPP test floor setup). Each animal’s drug-paired floor was
placed on the non-preferred side of the chamber during the test to ensure that side
preference did not artificially inflate CPP expression. On day 25, mice were returned to the
conditioning protocol for another 8 days for 4 more trials and a second CPP test on day 33.
This design offers the sensitivity to not only determine whether the fluid groups exhibit
stronger/weaker CPP for cocaine, but also whether CPP may develop after fewer/more
drug-cue pairings across 2 doses of drug. The durations of these sessions and drug doses
were chosen due to previously demonstrated success with cocaine CPP in B6 mice
(Cunningham et al., 1999).

Statistical Analysis

Experiment 1
Fluid intake was analyzed by repeated measures analyses of variance (ANOVAs)
with caffeine (yes or no) and ethanol (yes or no) consumption history as the between
subjects factors and day as the repeated within subjects factor. Ethanol and caffeine intake
were also specifically analyzed with fluid (E/EC or C/EC) as the between subjects factor
and day as the repeated within subjects factor.
Habituation activity during the first 2 days of the sensitization protocol was also
analyzed via repeated measures ANOVA with caffeine (yes or no) and ethanol (yes or no)
consumption history as the between subjects factors and day as the repeated within subjects
factor. The activity of CN mice was analyzed independently because this group does not
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contain the same 2 levels of the dose factor as in AC and RC groups and therefore cannot
be appropriately included in the overall analysis. Furthermore, the main experimental
question addressed was whether caffeine/ethanol consumption histories influence the
locomotor response to cocaine and CN mice never received cocaine in the experiment. A
repeated measures ANOVA with caffeine and ethanol consumption history as the between
subjects factors and day as the repeated within subjects factor for the activity of CN mice
on Days 3-11 of the sensitization protocol therefore evaluated whether baseline differences
existed, an important consideration in the interpretation of the response to cocaine in the
other groups. To determine fluid group and dose effects on cocaine locomotor sensitivity,
activity was specifically analyzed on Day 3 and Day 11 of the sensitization protocol with
caffeine consumption history, ethanol consumption history, dose (1,5 mg/kg), and
condition (AC,RC) as the between subjects factors. This approach was chosen because the
important experimental manipulations occur on these two days and thus determine whether
group differences exist. Furthermore, a repeated measures ANOVA across all 5 test days
is arguably unnecessarily complicated considering the inconsistent treatment history of the
AC group (saline on days 3-9 and cocaine on day 11). In order to evaluate whether repeated
cocaine exposure induced a progressive increase in locomotor activity in RC mice, a
sensitization score (SENZ) was computed for each mouse (Day 11 activity – Day 3
activity). SENZ scores for each fluid group significantly greater than ‘0’ as determined by
t-test indicate the existence of a sensitized locomotor response. In addition, direct
comparisons were planned between AC and RC groups within each dose for day 11 activity
in each fluid consumption group (W, C, E, EC). This planned analysis helped determine
whether the AC versus RC manipulation was successful in inducing sensitization within
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each fluid group, an important consideration obscured by the overall analysis of Day 11
activity. Bonferroni-corrected t-tests were employed for these planned comparisons.
Finally, regression analyses were conducted to assess whether prior ethanol or caffeine
intake via DID influenced any observed differences in cocaine sensitivity. Newman-Keuls
post-hoc statistics were run where applicable and the significance level was set at p < 0.05.
A total of 20 mice were removed from the analyses in Experiment 1 due to insufficient
caffeine intake as determined by the previously mentioned criteria (11 C), injection error
(1 EC) extremely anxious behavior (1 E, 1 W, 1 EC), escape from cage for a prolonged
period of time (2 W & 1EC), or death (1 W & 1 EC).

Experiment 2
Fluid intake was analyzed by repeated measures ANOVAs with caffeine and
ethanol consumption history as the between subjects factors and day as the repeated within
subjects factor. Ethanol and caffeine intake were also specifically analyzed with fluid
(E/EC or C/EC) as the between subjects factor and day as the repeated within subjects
factor.
Habituation activity was analyzed by a two-way ANOVA with caffeine and ethanol
consumption history as the between subjects factors. Activity data across CS+ and CStrials were separately analyzed by 4-way repeated measures ANOVAs with dose, caffeine
history, and ethanol history as the between subjects factors and conditioning trial as the
within subjects factor. The activity analysis of CS+ trials allows for comparison to the data
from Experiment 1 to assess whether locomotor sensitization differences are also apparent
in the context of place conditioning at the 5 mg/kg dose.
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The typical way in which CPP is analyzed is by comparing the mean
seconds/minute spent on the drug-paired floor relative to the saline paired floor during the
CPP test. Mice were counterbalanced for which floor texture was paired with cocaine
within each dose assignment and mean seconds/minute on the grid floor was compared
between mice that had the grid floor paired with cocaine (G+) and those that had it paired
with saline (G-). This allows for the most careful determination of whether CPP was indeed
achieved as the groups are compared solely on their different learning experience about
one common cue (the grid floor in this case) and this analysis is conventional in the place
conditioning literature (Cunningham et al., 1999; Cunningham et al., 2006). To determine
whether previous fluid consumption history influenced baseline floor preference, mice in
the ‘0’ dose group that never received cocaine were first compared for the time they spent
on the grid floor during the CPP tests. This was assessed via a 3-way repeated measures
ANOVA with caffeine and ethanol consumption history as the between subjects factors
and test as the repeated within subjects factor. For groups receiving cocaine, a repeated
measures ANOVA was employed with caffeine consumption history, ethanol consumption
history, dose (1 or 5 mg/kg), and grid floor assignment (G+ or G-) as the between subjects
factors and test as the repeated within subjects factor. CPP is also assessed by comparing
groups simply based on the time spent on the drug-paired floor. A repeated measures
ANOVA was also run to compare groups on this measure of CPP with caffeine
consumption history, ethanol consumption history, and dose (1 or 5 mg/kg), as the between
subjects factors and test as the repeated within subjects factor. Although not as stringent as
the analysis described earlier, this approach may allow for the detection of CPP that may
have been differentially influenced by which texture was assigned as the CS+. In addition,
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the G+/G- comparison does not provide a continuous measure with which to correlate prior
caffeine and ethanol consumption via DID. Regression analyses were conducted to assess
whether prior ethanol or caffeine intake via DID influenced any observed differences in
time spent on the drug-paired floor. Newman-Keuls post-hoc statistics were run where
applicable and the significance level was set at p < 0.05. A total of 5 mice were excluded
from the analyses of Experiment 2 due to insufficient caffeine intake (2 C), insufficient
ethanol intake (1 E), extremely anxious behavior (1 E), or death (1 C).
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RESULTS

Experiment 1

Fluid Consumption during DID
Across the 14 days of DID drinking, mice with a caffeine consumption history (C,EC)
consumed more total fluid than those that did not consume caffeine [F(1,250) = 7.295, p <
0.05] (Figure 12). Ethanol history significantly interacted with the repeated factor, day, and
indicated that mice with an ethanol consumption history (E,EC) significantly increased
their fluid intake over days [F(13,3250) = 10.312, p < 0.001]. The potential for differences
in caffeine or ethanol intake was also evaluated between groups. Although C and EC mice
did not differ in overall caffeine intake (p > 0.05), a significant fluid × day interaction
indicated that EC mice initially consumed slightly less caffeine than C mice on certain days
during the first half of DID [F(13,1625) = 9.176, p < 0.001] (Figure 13). Ethanol
consumption over the course of DID was not different between E and EC mice (p > 0.05),
however intake increased over days as previously reported [F(13,1742) = 35.650, p < 0.001]
(Figure 14).
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Habituation
To assess the influence of fluid consumption history on baseline activity in the
sensitization paradigm, habituation activity was analyzed across the first two days when
mice received saline injections prior to activity monitoring. A significant caffeine × day
interaction indicated that mice that had a caffeine consumption history were more active
than those that did not on Day 1 [F(1,250) = 4.478, p < 0.05], however groups were
equivalent by Day 2 (Figure 15). In addition, a caffeine × ethanol × day interaction
indicated that E mice demonstrated the least change in activity from Day 1 to Day 2
[F(1,250) = 3.992, p < 0.05].

Sensitization
Prior to the initiation of the sensitization protocol mice were counterbalanced for
caffeine/ethanol intake and baseline activity for dose and condition assignments (all p’s >
0.1). The activity data for all mice across the entire sensitization phase of the experiment
can be seen in Figures 16-19. For Days 3-11, the activity of only the CN mice in each fluid
group was first analyzed. This was done to determine whether or not basal activity was
generally influenced by fluid consumption history. As CN mice do not have 5 mg/kg or 10
mg/kg dose groups, it is not possible to include them in an overall analysis of condition
and dose on activity throughout Days 3-11. Neither caffeine (p > 0.05) nor ethanol (p >
0.05) consumption history influenced basal activity throughout Days 3-11. As the primary
objective of the study was to determine whether fluid consumption histories altered
locomotor responsivity to cocaine and these fluid consumption histories did not influence
basal activity, CN mice were excluded from the rest of the analyses.
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As the major differences between groups are determined on two key days of the
sensitization protocol, Day 3 and Day 11, locomotor activity was specifically analyzed on
these days in lieu of an unnecessarily complicated repeated measures analysis. The analysis
of Day 3 activity found main effects of caffeine history [F(1,195) = 13.083, p < 0.001],
dose [F(1,195) = 41.673, p < 0.001], and condition [F(1,195) = 232.868, p < 0.001] (Figure
20). Caffeine history positive mice were generally more active than those that were not
exposed to caffeine (p < 0.001) and RC mice (which received cocaine) were significantly
more active than AC mice (which received saline) (p < 0.001). The main effect of dose is
best explained by higher order interactions. A significant dose × condition interaction
[F(1,195) = 55.197, p < 0.001] indicated that within the RC groups, the 10 mg/kg dose
produced greater locomotor activity than the 5 mg/kg dose (p < 0.001) as expected. In
addition, a significant caffeine history × dose × condition interaction [F(1, 95) = 8.605, p
< 0.01] indicated that among the RC mice that received the higher 10 mg/kg dose, those
that had a positive caffeine history (C,EC) were significantly more stimulated than those
that did not (p < 0.01). Therefore, prior caffeine consumption produced the greatest initial
locomotor stimulant response to the 10 mg/kg dose of cocaine.
The analysis of Day 11 activity, when mice in the AC condition received their first
dose of cocaine and RC mice received their fifth dose, found main effects of dose [F(1,195)
= 65.674, p < 0.001] and condition [F(1,195) = 22.229, p < 0.001] with mice receiving the
10 mg/kg dose and mice in the RC group demonstrating significantly greater stimulant
responses to cocaine than 5 mg/kg and AC mice, respectively (Figure 21). In addition, a
caffeine history × dose interaction neared significance [F(1, 195) = 3.559, p = 0.06],
indicating a trend for mice with a positive caffeine history being activated to a greater
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extent by the 10 mg/kg dose on Day 11 than those that had no prior experience with caffeine.
This characterization of sensitization accounts for the possibility that repeated injection
stress influences the development of locomotor sensitization. In this case, sensitization is
defined by significantly greater activity in the RC group compared to the AC group in
response to a common dose of drug and this was observed in the current study. Although
RC groups were indeed generally more activated by cocaine than AC mice on Day 11, it is
also of interest how the various injection conditions influenced locomotor behavior on Day
11 in each fluid group. This information assists in the interpretation of the overall Day 11
activity analysis because it more carefully addresses whether the injection protocol did
indeed produce sensitization in each fluid group. This question is obscured by the
complexity of the overall ANOVA.
In order to determine whether this indeed occurred in the current study, Bonferroni
corrected T-tests compared the Day 11 activity of RC and AC mice in each dose group,
within each fluid group. Among the C mice, repeated 5 mg/kg [t(23) = 2.509, p < 0.01;
one-tailed] and 10 mg/kg cocaine [t(23) = 2.234, p < 0.05; one-tailed] induced significant
sensitization relative to the acute injection (Figure 16). Within E mice, neither the 5 mg/kg
(p > 0.05) nor the 10 mg/kg dose (p > 0.05) produced sensitization as determined by this
analysis (Figure 17). In EC mice, repeated 5 mg/kg cocaine did not increase the locomotor
response relative to the acute injection (p > 0.05). However, repeated doses of 10 mg/kg
cocaine was effective in increasing this response [t(27) = 1.975, p < 0.05; one-tailed]
(Figure 18). W mice that received repeated doses of 5 mg/kg mice were stimulated similarly
to those receiving an acute injection (p > 0.05). However, repeated 10 mg/kg cocaine
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robustly augmented the stimulant response relative to an acute injection [t(20) = 4.004, p
< 0.001; one-tailed] (Figure 19).
As sensitization is also classically defined as a successive increase in response to a
fixed dose of drug with repeated administration, this was also evaluated within the RC mice.
A ‘SENZ’ score was calculated for each RC mouse as follows: SENZ = (Day 11 activity –
Day 3 activity). This difference score therefore reflects the change in locomotor activity
from the first cocaine exposure to the last, with positive values reflecting sensitization. In
order to determine whether mice expressed sensitization, SENZ score means were
compared to ‘0’ for each fluid/dose group via t-test. Among the 5 mg/kg RC mice, only W
[t(12) = 3.94, p < 0.01)] and EC [t(13) = 3.94, p < 0.01)] mice had mean SENZ scores
significantly greater than 0 (Figure 22A). Among the RC mice receiving 10 mg/kg, only
the W mice demonstrated a significant SENZ score [t(10) = 3.694, p < 0.01)] which was
particularly robust (Figure 22B). Overall ANOVAs were not deemed appropriate for these
analyses of SENZ as relative comparisons of SENZ are not very meaningful if not all
groups express significant SENZ in the first place.

Relationship between Prior Caffeine/Ethanol Intake and Cocaine Stimulation
In order to determine how caffeine intake was related to the observed group
difference in acute cocaine stimulation on Day 3 in RC 10 mg/kg mice, a linear regression
analysis was performed to determine the predictive value of mean caffeine intake
throughout DID for Day 3 activity of these C and EC mice. This analysis found no
relationship between the relative amount of caffeine consumed and locomotor activity on
day 3 (p > 0.05; R2 < 0.001; Figure 23A). The same analysis was conducted for prior
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ethanol intake and Day 2 activity and again, no relationship was found (p > 0.05; R2 = 0.03;
Figure 23B). Therefore prior caffeine consumption, regardless of relative levels of
consumption, heightened sensitivity to the acute stimulant response to the 10 mg/kg
cocaine dose.

Experiment 2

Fluid Consumption during DID
Across the 14 days of DID drinking, mice with an ethanol consumption history
consumed more total fluid than those that did not consume ethanol [F(1,231) = 5.917, p <
0.05] (Figure 24). Ethanol history significantly interacted with the repeated factor, day, and
indicated that mice with an ethanol consumption history significantly increased their fluid
intake over days [F(13,3003) = 7.229, p < 0.001]. The potential for differences in caffeine
or ethanol intake was also evaluated within each group. EC mice were found to consume
slightly more caffeine, overall, than C mice [F(1,115) = 4.258, p < 0.05] (Figure 25). A
significant fluid × day interaction indicated that EC mice generally increased their intake
over days and consumed significantly more caffeine than C mice specifically on days 1114 of DID [F(13,1495) = 6.721, p < 0.001]. Ethanol consumption over the course of DID
was not different between E and EC mice (p > 0.05), although ethanol intake generally
increased over days as previously reported [F(13,1508) = 47.34, p < 0.001] (Figure 26).
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Habituation
On day 1 of the CPP protocol, basal activity was measured during the habituation
session. Neither caffeine (p > 0.05) nor ethanol (p > 0.05) consumption history influenced
basal locomotor activity on Day 1 (Figure 27). Mice were counterbalanced for dose (0, 1,
or 5 mg/kg cocaine), drug-paired floor (GRID+ or GRID-), and drug exposure day (odd or
even) on the basis of mean ethanol/caffeine intake during DID and day 1 locomotor activity
(p’s > 0.1).

Locomotor Activity during Conditioning
Activity during CS- (saline only) trials (Figure 28) and CS+ (cocaine) trials (Figure
29) were analyzed separately. For control mice in the ‘0’ dose group, roughly half of the
mice have data represented from odd days and the other half have data represented from
even days. This approach was taken because although these mice never receive cocaine,
data from each day of each trial is represented. During drug-free CS- trials, mice in the 5
mg/kg dose group were significantly more active than mice in the 0 and 1 mg/kg groups
[F(2,223) = 21.636, p < 0.001], perhaps indicating some degree of conditioned locomotion
(Figure 28). In addition, a significant trial × dose interaction [F(14,1561) = 2.067, p < 0.05]
indicated that the 5 mg/kg group was particularly active during trials 6-8 (p’s < 0.05).
Finally, a significant trial × dose × ethanol history interaction [F(14,1561) = 1.943, p <
0.05] determined that mice that had previously consumed ethanol in the 5 mg/kg group
were particularly active during trials 6-8 (p’s < 0.05).
During CS+ trials, where the 1 and 5 mg/kg dose groups received cocaine, a main
effect of dose [F(2,223 = 83.158, p < 0.001] determined that the 5 mg/kg group was
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significantly more active than the other groups (p’s < 0.001; Figure 29). In addition, a main
effect of trial [F(7,1561) = 6.391, p < 0.001] indicated that activity was significantly lower
on trials 5-8 relative to trials 1-4 (p’s < 0.05). Finally, a significant trial × ethanol history
interaction [F(7,1561) = 2.078, p < 0.05] indicated that mice that had consumed ethanol
(E,EC) were generally less active on trials 5-8 relative to trials 1-4 (p’s < 0.05). All other
main effects and interactions did not reach statistical significance (p’s > 0.05).

Conditioned Place Preference
Prior to CPP analysis, all 0 dose group mice were compared for their time spent on
the grid floor for across the CPP tests to determine whether prior fluid history may have
influenced time spent on the grid floor in a neutral condition. Neither caffeine (p > 0.05)
nor ethanol (p > 0.05) history was found to influence time spent on the grid floor among
mice in the 0 group during CPP tests (Figure 30). Test was also not a factor (p > 0.05) and
none of the potential interactions reached statistical significance (p’s > 0.05). Activity
during the CPP tests was also analyzed within the 0 dose group to determine if prior fluid
consumption history influenced activity specifically during testing conditions. Neither
fluid history (p’s > 0.05) nor test number (p > 0.05) influenced activity during CPP tests
(Figure 31). As this group of mice did not receive cocaine at any point and therefore did
not have a G+ and G- designation, it was excluded from further analyses.
Time spent on the grid floor for Test 1 and Test 2 are represented in Figures 32 and
33, respectively. For the CPP test analysis, time spent on the grid floor was compared
between mice that had the grid floor paired with cocaine (G+) and mice that had the grid
floor paired with saline (G-). A main effect of grid floor assignment [F(1,180) = 87.16, p <
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0.001] indicated that G+ mice spent significantly more time on the grid floor than G- mice,
suggesting that the CPP protocol was effective in producing CPP for cocaine. In addition,
a significant dose × grid floor assignment interaction [F(1,180) = 37.02, p < 0.001]
demonstrated that although G+ mice spent more time on the grid floor than G- in both the
1 and 5 mg/kg groups (p < 0.05), this difference was far more pronounced in the 5 mg/kg
group (p < 0.001). Finally, a significant test × grid floor assignment interaction [F(1,180)
= 4.75, p < 0.05] revealed that the difference between G+ and G- groups increased in Test
2 (p’s < 0.05), suggesting a strengthening of conditioning. All other main effects and
interactions did not reach statistical significance (p’s > 0.05). Therefore, prior fluid
consumption in DID had no bearing on cocaine CPP development or expression.
Although this is viewed as the most rigorous statistical approach to assess CPP
because it is strictly comparing the learning that took place for a consistent cue (the grid
floor), another common analysis is to compare the amount of time animals spent on the
drug-paired floor. This other analysis offers increased power and simplicity to detect
potential differences in CPP as it removes the G+ and G- distinction. This analysis only
found a main effect of dose [F(1,188) = 34.15, p < 0.001] with the 5 mg/kg dose producing
greater times on the drug-paired floor (Figure 34). In line with the analysis above, the main
effect of test approached significance [F(1,188) = 3.16, p = 0.07] suggesting conditioning
may have been slightly stronger in Test 2 relative to Test 1. All other main effects and
interactions did not reach statistical significance (p’s > 0.05).
The analysis of activity during drug-free CPP tests revealed that mice that had been
receiving the 5 mg/kg dose were significantly more active than the 1 mg/kg group [F(1,188)
= 21.698, p < 0.001], suggesting conditioned locomotion evident during CS- trials in the
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higher dose group may have also carried over to the CPP tests (Figure 35). Caffeine history,
ethanol history, and test number all had no bearing on test activity and none of the potential
interactions reached statistical significance (p’s > 0.05).
Although DID fluid consumption history did not influence either of these measures
of CPP, group differences may have emerged at certain time points within the CPP tests
that this analysis was not able to detect. Time spent on the drug floor was compared
between test groups across the 3, 5-minute bins of each 15-minute CPP test. The results of
the repeated measures analyses of both Test 1 [F(1,188) = 17.946, p < 0.001] and Test 2
[F(1,188) = 30.64, p < 0.001] yielded identical results to the earlier analysis, with only a
significant effect of dose indicating that the 5 mg/kg group spent significantly more time
on the drug-paired floor, overall, in each test (Figures 36 & 37). All other main effects and
interactions did not reach statistical significance (p’s > 0.05). Therefore, no fluid group
differences emerged early or late in the CPP tests.
With the evidence of conditioned locomotor activity in the CPP tests, it is important
to determine whether this increased activity may have interfered with CPP expression. If
mice are sufficiently active, their ability to remain on one side and demonstrate preference
or aversion could be hampered and this has been seen in previous CPP work with cocaine
(Cunningham et al., 1999). To address this, regression analyses were run for both tests to
address whether activity was negatively predictive of time spent on the drug-paired floor.
For test 1, activity was actually positively predictive of time spent on the drug-paired floor
[F(1,194) = 16.25, p < 0.001; R2 = 0.077] (Figure 37A). However, no effect was found for
test 2 (p > 0.05; R2 = 0.011] (Figure 37B). Therefore, any conditioned effect on locomotion
does not appear to have interfered with CPP expression.
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Relationship between Prior Caffeine/Ethanol Intake and Cocaine CPP
In light of the small caffeine intake difference between C and EC mice, regression
analysis evaluated the predictive ability of mean caffeine intake during DID on the time C
and EC animals spend on the drug-paired floor for both tests. Caffeine intake during DID
was not a significant factor in either test (p’s > 0.05; Figure 38A,C). For comparative
purposes, the same analysis was carried out for ethanol groups and again, previous intake
was not predictive of time spent on the drug-paired floor in either test (p’s > 0.05; Figure
38B,D).
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DISCUSSION

The objective of Experiment 1 was to determine whether a history of binge
consumption of caffeine, ethanol, or their combination influenced the locomotor stimulant
response or the capacity to develop locomotor sensitization to the psychostimulant drug,
cocaine. The objective of Experiment 2 was to determine whether these prior drinking
histories influenced cocaine conditioned ‘reward’ as assessed by the CPP paradigm. It was
found that caffeine consumption, either with or without ethanol, increased the initial
locomotor stimulant response to the highest dose of cocaine used in the study (10 mg/kg).
However, these prior fluid consumption histories were not found to influence the
expression of cocaine CPP. These results suggest that prior caffeine, but not ethanol,
consumption increases sensitivity to the stimulant response of cocaine, however the
conditioned rewarding effects of lower doses were not altered.

Experiment 1: Locomotor Sensitization
In Experiment 1, no differences were found in ethanol or caffeine intake between
groups across the 14-day DID pre-exposure period (Figures 13 & 14). This is in line with
our previously published work with this model (Fritz et al., 2014). The onlyknown
published animal study that observed an effect of voluntary caffeine co-consumption on
ethanol intake was in female selectively-bred alcohol preferring rats (Franklin et al., 2013).
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The drinking paradigm was similar with 1hr limited daily access for 14 days, using the
same caffeine concentration (0.03% w/v) and a slightly lower ethanol concentration (15%
v/v). Animals were found to consume significantly more of the caffeinated ethanol solution
than either ethanol or caffeine alone. Recently, we also observed increased ethanol intake
via caffeine co-consumption in adolescent and adult male B6 mice via DID when the access
period was extended from to 2hr to 4hr (Fritz et al., in press). It is not entirely clear why
caffeine does not influence binge ethanol intake in 2hr DID in adult male B6 mice, however
genotype, sex, and ethanol concentration may be important factors. Perhaps the genetic
predisposition for high alcohol intake in P rats enhances the capacity for caffeine to
influence ethanol consumption. Female rats and mice have also been consistently observed
to consume more ethanol than male animals in voluntary access paradigms (Li et al., 1993;
Matson and Grahame, 2013; Rhodes et al., 2005), perhaps increasing the likelihood that
caffeine may alter the interaction with ethanol. In addition, caffeine may exert a stronger
influence over the consumption of lower concentrations of ethanol. Caffeine has been
observed to enhance the stimulant properties of low/moderate doses of ethanol (Hilbert et
al., 2013; Kuribara et al., 1992; May et al., 2015; Waldeck, 1974) and may therefore
potentially increase sensitivity to lower concentrations of ethanol. Although a primary
concern in the human literature is that the high amount of caffeine in energy drinks may
encourage dangerously high levels of ethanol consumption, it could be argued that the lack
of caffeine or ethanol consumption differences between groups in the current experiment
is an interpretational strength. Because these intakes are equivalent, any differences
observed in cocaine-induced locomotor stimulation and/or sensitization are likely due to
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the caffeine/ethanol consumption history and not relative differences in the amounts
caffeine or ethanol consumed.
At the initiation of the locomotor sensitization protocol, mice were habituated to
the activity testing boxes and received saline injections on days 1-2. This allowed for the
determination of any baseline differences in activity or the capacity to habituate to the
testing chamber, both of which were important interpretational considerations for the
remainder of the experiment. Mice that had previously consumed caffeine (C,EC) were
found to be significantly more active than those that had not on Day 1 (Figure 15). However,
the activity of all fluid groups was equivalent by Day 2. Prior caffeine exposure may
therefore have interacted with the novelty of the activity testing chamber and these mice
may have been somewhat more exploratory. Acute caffeine treatment has been shown to
increase the response to novelty in both animals (Hughes and Greig, 1976) and humans
(Davidson and Smith, 1991). Furthermore, a heavy caffeine consumption history has been
associated with a greater propensity for novelty-seeking in humans (Gurpegui et al., 2007).
Surprisingly, a literature search yielded no published studies directly addressing the effect
of prior caffeine on novelty responses or seeking in animals. This seems to be an important
question to address given the demonstrated overlapping relationships between novelty
seeking (Bardo et al., 1996; Palmer et al., 2013; Wills et al., 1994) and caffeine use
(Kendler et al., 2006) with drug seeking and use/abuse. Nevertheless, the activity of all
groups was equivalent by Day 2, suggesting that no baseline differences in activity existed
which could have influenced subsequent observations on Days 3-11. This was further
confirmed by the analysis of activity among CN mice on Days 3-11 which revealed no
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influence of prior caffeine or ethanol consumption histories on baseline activity (Figures
16-19).
On Day 3, mice in the RC groups experienced their first dose of cocaine. Not
surprisingly, cocaine stimulated locomotor activity with the 10 mg/kg dose producing
stimulation greater than the 5 mg/kg dose (Figure 20). Interestingly, mice that had
previously consumed caffeine irrespective of ethanol (C,EC) were significantly more
stimulated by the 10 mg/kg cocaine dose than those not previously exposed to caffeine
(E,W). Although this may be evidence for cross-sensitization in mice that had previously
consumed caffeine, the data collected on Day 11 determine whether group differences
emerged in sensitization development over the course of the experiment. On Day 11, RC
groups received their fifth dose of cocaine and AC received their first dose. Significantly
greater activity in RC groups relative to AC groups indicates that repeated cocaine
administration induced a sensitized response greater than a single acute injection. Not
surprisingly, mice that had received the 10 mg/kg dose (collapsed on AC and RC) were
also more stimulated than those that were given the 5 mg/kg dose (Figure 21). The observed
statistical trend for mice that did not consume caffeine to have a lower response to the 10
mg/kg dose (collapsed on RC and AC) appears to be driven by a dampened response in W
AC mice in the 10 mg/kg group. Therefore, prior caffeine and ethanol intake (alone or in
combination) may have also positively influenced the acute response to 10 mg/kg cocaine
11 days after the cessation of DID.
Sensitization was also assessed within each fluid group by directly comparing the
Day 11 activity of AC and RC groups for each dose. Although the overall ANOVA on Day
11 technically made this comparison, its complexity obscures the question of whether the
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various injection conditions produced the expected pattern of results in each fluid group.
In other words, it is still important to address whether repeated cocaine in each fluid group
indeed produced greater stimulation than an acute injection in order to more carefully
interpret the results of the overall analysis of Day 11 activity. It was found that only mice
consuming caffeine alone expressed this characterization of sensitization to the 5 mg/kg
dose of cocaine (Figure 16). In addition, all fluid groups, except for mice that consumed
ethanol alone, demonstrated this characterization of sensitization to the 10 mg/kg dose of
cocaine (Figures 16-19).
The above findings are best interpreted when also considering the SENZ score
(change in activity from Day 3 to Day 11) for RC mice. Analysis of the SENZ score
indicated that the cocaine-induced stimulation response was significantly increased only in
W and EC groups receiving the 5 mg/kg dose (Figure 22A). In addition, only W mice
exhibited a significant increase in activity via repeated exposure to the 10 mg/kg dose
(Figure 22B). Given the observation that relative stimulation by cocaine did not increase
with repeated exposures in 10 mg/kg C and EC mice, prior caffeine consumption may have
cross-sensitized mice to the 10 mg/kg dose to the fullest extent possible on Day 3. It is also
important to note that 10 mg/kg AC groups did demonstrate lower levels of stimulation
than RC groups on Day 11 (except for mice that consumed ethanol, only). Therefore, the
time between the cessation of DID and first cocaine exposure appears to be an important
factor in this response. Indeed, previous work has demonstrated that significant
neurobiological changes induced by chronic caffeine intake in mice can be normalized
within 7 days following the cessation of caffeine consumption (Shi et al., 1994). Perhaps
by Day 11, any changes in neurobiology/neurochemistry induced by prior caffeine
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consumption were diminishing and as such, the acute response to cocaine was dampened.
This may also explain the observation of significantly greater activity in RC 5 mg/kg mice
relative to the AC group in mice consuming caffeine, only (Figure 16). This possibility is
also supported by the fact that that RC 5 mg/kg mice in the C group did not achieve a
significant SENZ score (Figure 22A). Therefore, continued cocaine exposure may maintain
these observed higher levels of initial response in mice that had consumed caffeine in DID.
Interestingly, the relative level of caffeine intake was not related to the observed increased
stimulant response to 10 mg/kg cocaine on Day 3 in mice that had previously consumed
caffeine (Figure 23A). The same was true for prior ethanol consumption (Figure 23B).
Therefore, a caffeine consumption history of at least 5.7 mg/kg/day in DID, elevated the
initial stimulant response to 10 mg/kg cocaine soon after the cessation of caffeine
consumption.
Alternatively, repeated injection stress could have potentially dampened the
response to cocaine in mice that previously consumed caffeine. If injection stress was
indeed interfering with cocaine stimulation/sensitization, it could be acting as an opponent
process, resulting in no change in activity in RC 10 mg/kg groups. The acute response of
AC mice on Day 11 could also be dampened as a result. This could explain the null SENZ
score in their respective RC 10 mg/kg groups as well as significantly greater Day 11 activity
relative to AC 10 mg/kg groups. This may also offer an explanation for similar results in C
mice that had received 5 mg/kg of cocaine. A simple follow up study could address whether
repeated injection stress may have been a factor in these observations. Following 2 weeks
of DID drinking, mice could be assigned to a group that receives saline injections until Day
11 where they receive their first injection of cocaine (AC condition) or another group that
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receives its saline injections on Days 9-10 and its first cocaine injection on Day 11. The
standard AC condition could be slightly altered to also receive saline on Day 10 to keep
the chamber exposure consistent. This design keeps the duration following the cessation of
DID before receiving cocaine consistent and compares the effect of 2 prior saline injections
versus 7 prior saline injections on acute cocaine responsiveness, thus answering the
question of whether repeated injection stress may have differentially influenced the
locomotor stimulant response to cocaine as a result of various fluid consumption histories.
These findings would clarify whether repeated injection stress indeed contributed to the
results of the initial study.
Nevertheless, these findings suggest that prior caffeine consumption crosssensitized mice to the psychomotor stimulant effect of cocaine soon after the cessation of
caffeine consumption. This observation is in line with previous findings in rats (Gasior et
al., 2000; Jaszyna et al., 1998; O'Neill et al., 2015). However, there are key differences
between these studies and the current one that are worth noting. In the study by Jaszyna
and colleagues (1998), caffeine consumption was forced by adding an extremely high
concentration of caffeine (0.3 % w/v; 10 times the concentration used in the current study)
to the rats’ drinking water, resulting in daily intakes approaching 175 mg/kg/day. For a
frame a reference, a 70 kg individual would need to consume an astounding 122.5 cups of
coffee (assuming 100 mg per 8 oz serving) per day to reach that level of dosing. Of course,
the pharmacokinetics of a human are very different than that of a rat, but even so, a standard
‘cup of coffee’ equivalent in rodents has been estimated at a dose of around 5 mg/kg when
accounting for pharmacokinetic factors (Fredholm et al., 1999). Even after this
consideration, the level of caffeine intake in these rats would be roughly equivalent to a
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still extremely high level of 35 standard cups of coffee. This extreme caffeine intake does
not appear to have much translational relevance. In addition, the rats in this study were
responding for food in an operant paradigm and the observation of a sensitized motor
response was an increased response rate induced by cocaine in rats that had been
consuming caffeine. Interestingly, the largest differences observed between groups was at
a cocaine dose of 10 mg/kg, consistent with the current study.
The study by O’Neil and colleagues (2015) also forced caffeine consumption in
their experimental animals, although the concentration was identical to the current study
(0.03% w/v). This resulted in daily intakes of ~25-35 mg/kg for a period of 4 weeks, a
much more translationally-relevant dose range (equivalent of ~5-7 cups of coffee). One
major difference was that they were testing both adolescent and adult rats that had
previously consumed caffeine. They observed that prior caffeine consumption as an
adolescent, but not as an adult, increased the locomotor stimulant response to 15 mg/kg of
cocaine (a higher dose than that used in the current study; 10 mg/kg). The locomotor
activity assessment, however, was over a period of 4 hours with rats receiving increasing
doses of cocaine each hour (0, 2.5, 7.5, 15 mg/kg). This finding is not very clear, however.
Although animals previously exposed to caffeine as adolescents and adults were not
compared statistically, the age-specific effect appears to be driven by a slightly decreased
response to 15 mg/kg of cocaine in adolescent water controls and a high degree of
variability in both the caffeine and water adult groups. Furthermore, this progressive dosing
design, requiring 4 successive injections within the same session, may be more prone to
the influence of repeated stress. As previously mentioned, stressors can act to cross-
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sensitize animals to the effects of stimulant drugs of abuse (Robinson, 1988). Therefore,
these previous findings are not entirely clear.
Finally, Gasoir and colleagues (2000) also employed a forced access model of
caffeine intake in adult rats. The caffeine concentration was also similar to that employed
in the current study (0.025% w/v) and produced translationally-relevant daily caffeine
intakes ~20-25 mg/kg. It was found that a high 30 mg/kg dose of cocaine produced
particularly robust locomotor stimulation in rats consuming caffeine. One major difference
relative to the current study, however, is that caffeine remained in the drinking water
throughout behavioral testing. Therefore, it cannot be ruled out that this observation is due
to an additive stimulant effect of cocaine and caffeine as has been previously reported
(Bedingfield et al., 1998).
Previous studies have demonstrated that rats and mice sensitized to cocaine exhibit
cross-sensitization to ethanol (Itzhak and Martin, 1999; Lessov and Phillips, 2003) and vice
versa (Itzhak and Martin, 1999), although this was observed at a dose double of that used
in the current study (20 mg/kg). These prior studies employed experimenter-administered
injections of ethanol. A main concern with this approach is that non-contingent
drug/alcohol exposure can produce very different effects and experimenter administration
lacks translational validity (Jacobs et al., 2003; Moolten and Kornetsky, 1990). As such,
the primary goal of the current study was to address whether voluntary ethanol, caffeine,
or co-consumption influenced cocaine sensitivity. Of course, the mice in the current studies
were receiving experimenter-administered injections of cocaine, which may seem
incongruent with this concern. However, the experimental design allowed for any
alterations in the observed locomotor response to cocaine to be attributable to fluid
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consumption history. Therefore, any neurobiological/neurochemical adaptations that may
have occurred as a result of prior caffeine/ethanol exposure would account for any
differential response cocaine. Self-administration paradigms produce differing levels and
patterns of drug intake that makes interpretations of drug sensitivity difficult. So although
mice were not self-administering cocaine in the current study, employing fixed doses of
cocaine allows for clearer interpretation of cocaine sensitivity which may have implications
for later assessments of self-administration behavior. Nevertheless, mice that consumed
ethanol only in DID exhibited no evidence of either characterization of sensitization in the
current study. Although cocaine clearly stimulated activity in these mice, there is no
evidence that repeated cocaine exposure positively influenced locomotor stimulation at
either dose. The other three fluid consumption groups expressed at least some evidence of
cocaine sensitization.
In genetically heterogeneous mice, a history of prior ethanol injections (2.0-2.5
g/kg) did not influence the acute locomotor responses to a range of cocaine doses (5-20
mg/kg) in females (Lessov and Phillips, 2003; Wise et al., 1996), however crosssensitization to 20 mg/kg cocaine was observed in male animals (Itzhak and Martin, 1999).
In addition, three weeks of forced heavy ethanol consumption (23-28 g/kg/day) was not
observed to influence the initial response to 10 mg/kg cocaine in male mice, although
repeated cocaine exposure produced an increase in cocaine-stimulated locomotion only in
mice that previously consumed ethanol (Manley and Little, 1997). Finally, a study
evaluating the effect of repeated ethanol injections during adolescence on later cocaineinduced stimulation found that females previously exposed to ethanol demonstrated
enhanced locomotor stimulation by 1 mg/kg cocaine relative to females that had received
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saline during adolescence (Mateos-García et al., 2015). However, this effect was not
apparent at higher doses (5-20 mg/kg). Ethanol-exposed male mice exhibited blunted
sensitivity to 20 mg/kg cocaine, but responded similarly to saline-treated mice at lower
doses (1-10 mg/kg). In light of these findings, it is possible that the 10 mg/kg dose was not
sufficient to detect an enhanced stimulant response to cocaine as a consequence of prior
DID ethanol consumption. Alternatively, ethanol intake in the current study may not have
produced BECs high enough to influence locomotor sensitivity to cocaine. Injections at the
doses of ethanol used in these prior studies (2.0-2.5 g/kg) as well as the extreme ethanol
intake in the study by Manley and Little (23-28 g/kg/day) would be expected to produce
BECs around 200-250 mg/dl by injection and potentially similar, or even higher, levels
produced by consumption. The ethanol intake in the current study would be expected to
produce average BECs in the range of 120-160 mg/dl (Figure 9). Nevertheless, mice in the
other 3 fluid groups demonstrated some evidence of sensitization. Therefore, binge-like
ethanol intake, alone, via DID may have somehow blunted the potential for cocaine to
induce significant neuroadaptation resulting in sensitization.
This is the first known investigation of the effect of prior voluntary binge caffeine,
ethanol, or co-consumption on the locomotor sensitization capacity for cocaine. The results
demonstrated that a history of binge caffeine, but not ethanol, consumption in adulthood
can increase sensitivity to the locomotor stimulating effect of a moderate dose of cocaine,
perhaps indicating cross-sensitization. Although this has been previously observed as a
consequence of forced, continuous adolescent caffeine consumption in rats (O'Neill et al.,
2015), this is the first observation of this effect in adult animals that had previously
consumed caffeine. Therefore, the age of caffeine pre-exposure does not appear to be a

71
critical factor for this effect. In addition, mice in the current study consumed approximately
8-11 mg/kg of caffeine in each 2hr DID session, less than half of the daily caffeine intake
of rats in the study by O’Neil and colleagues (25-35 mg/kg). Therefore, substantially lower
total dosing of caffeine can also augment the cocaine locomotor stimulant response. It may
be that binge-like caffeine consumption in a short period of 2hrs via DID produces a
substantial accumulation of caffeine in the brain, thus eliciting this effect with lower total
caffeine dosing. Furthermore, this observation occurred at a lower dose of cocaine than the
previous study (10 mg/kg vs 15 mg/kg), suggesting that this level of limited-access caffeine
intake may further enhance cocaine sensitivity. Finally, a significant SENZ score for the
moderate dose of cocaine was only observed in W mice, suggesting that this elevated
stimulant response may possibly be indicative of maximal sensitization on the very first
cocaine exposure.
The findings of this experiment suggest that a modest level of caffeine exposure
(equivalent of ~2 cups of coffee a day) has the capacity to enhance the stimulant effects of
cocaine. This is of potential concern for public health as this elevated response may be
indicative of increased abuse liability. Rodent studies suggest that a sensitized locomotor
response is highly persistent and may be associated with a greater propensity to selfadminister psychostimulants and elevate drug-seeking behavior during abstinence (to be
discussed in further detail below). Indeed, a carefully controlled twin study found that
caffeine use was associated with cocaine abuse/dependence in humans (Kendler et al.,
2006). Together, these findings suggest that even modest caffeine intake may have harmful
implications for individuals’ early interactions with cocaine.
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Experiment 2: Conditioned Place Preference
In Experiment 2, EC mice were found to consume slightly more caffeine than C
mice. However, ethanol intake between E and EC mice was equivalent. Although small,
the difference in caffeine intake between EC and C mice was considered in the
interpretation of subsequent CPP analysis. However, it is important to note that the amount
of caffeine consumed during DID was very similar to that in the Experiment 1 (~8-11
mg/kg).
On Day 1 of the CPP protocol, mice were habituated to the CPP chamber and
exposed to a neutral paper floor cue. Activity on this day determined whether group
differences existed in baseline activity. This baseline activity measure was not influenced
by DID fluid consumption history (Figure 27). This appears to be inconsistent with Day 1
activity data in Experiment 1 where mice that had previously consumed caffeine were
significantly more active than those that had not (Figure 15). One reason for this could be
that the Plexiglas box used in CPP was significantly smaller than that used for locomotor
sensitization. Perhaps the larger space was more reflective of group differences in noveltyseeking or potentially anxiety-like behavior as these are behaviors commonly measured in
the classic open field task (Britton et al., 1982; Prut and Belzung, 2003).
Baseline activity was also not found to be different in saline control mice
throughout the 8 training trials (Figures 28 & 29). Therefore any differences between
groups could be attributed to dose and/or fluid consumption history. Across the CS+ trials
where mice received cocaine with their assigned paired floor cue, the 5 mg/kg dose
effectively stimulated locomotion whereas the 1 mg/kg dose did not (Figure 29).
Furthermore, a progressive increase in the locomotion was not apparent in any fluid group,
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indicating that cocaine locomotor sensitization was not observed during CPP training. In
fact, activity was actually significantly lower during later CS+ trials (Figure 29). The
reason for this is not clear, however this decrease took place after the first CPP test. Perhaps
the CPP test was somehow anxiogenic or even produced modest extinction of conditioned
locomotion. This is possible because psychostimulants, including cocaine, have been
shown to produce strong conditioned locomotor stimulation (Vezina and Leyton, 2009).
Indeed, mice that had received 5 mg/kg cocaine during training were significantly more
active than the 1 mg/kg groups during testing, suggesting conditioned locomotion carried
over to the drug-free test. Perhaps exposure to the drug-paired cue during the CPP test, in
the absence of cocaine, may have extinguished conditioned locomotion to some degree.
For drug free CS- trials, mice that were receiving 5 mg/kg of cocaine on their drugpaired floors were again significantly more active than the other groups, perhaps indicating
conditioned locomotion also occurred to the CPP process, in general (Figure 28).
Interestingly, activity was found to be increased in the 5 mg/kg mice during the last 4 trials
following Test 1, an effect opposite of that observed in CS+ trials. The fact that these
observations are opposite of those in CS+ trials is somewhat puzzling. Repeated exposure
to psychostimulants has been observed to produce sensitization to the point of stereotypic
behavior, such as head bobbing and incessant grooming (Janetsian et al., 2015; Kuczenski
et al., 1991), behaviors which have previously interfered with locomotor activity
assessments in rodents. This seems unlikely in the current study, however, as neither the 5
mg/kg nor 10 mg/kg RC groups in Experiment 1 exhibited any indication of stereotypic
behavior. Another possibility is that although conditioned locomotion was still intact, mice
developed tolerance to the stimulant effects of 5 mg/kg cocaine. Again, this seems unlikely
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as no evidence of tolerance to cocaine locomotor stimulation (RC group significantly less
activated than AC group) was observed in Experiment 1. In addition, tolerance to this effect
of cocaine has been observed after a long period of abstinence (60 days) but not after a
shorter period of abstinence (14 days) (Ben-Shahar et al., 2005). It is therefore unclear why
locomotor activity during CS+ trials diminished over time in the current study.
These findings differ from the observations of locomotor activity in Experiment 1
where there was some evidence of sensitization to repeated dosing of 5 mg/kg cocaine in
EC and W mice. Furthermore, the only influence of fluid history on cocaine-stimulated
activity was a very slight decrease in latter half of the Experiment 2 in mice that previously
consumed ethanol (E,EC). There are a couple of distinct differences between these
experiments that may explain these apparent inconsistencies. Firstly, mice were injected
and placed in the CPP boxes daily, whereas mice undergoing the sensitization protocol
were exposed to the box and injected every other day during the induction phase of the
experiment (Days 3-11). This equates to far more exposure to the box and injection
procedure in mice that underwent CPP. In addition, mice that were receiving cocaine during
CPP were also receiving saline injections during CS- trials. Therefore, mice in the
sensitization experiment that were receiving repeated cocaine only had the activity box and
injection procedure associated with a cocaine dose during the induction phase, whereas
mice in the CPP experiment were receiving both cocaine and saline associated with
injections and the box. Therefore, any effect of conditioned locomotion to the procedure
could have more strongly influenced the observation of sensitization in Experiment 1. It
also cannot be ruled out that the far larger space the mice had in the activity chamber in
Experiment 1 allowed group differences to more easily emerge. Upon examination of the
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total distance traveled for mice receiving 5 mg/kg in Experiment 1 (~5,000-7,500 cm;
Figures 16-19) versus Experiment 2 (~1,500-2000 cm; Figure 29), this larger space clearly
resulted in substantially more locomotion which may have ultimately contributed to the
expression of these fluid group differences in Experiment 1.
The CPP analyses revealed that the protocol was effective in producing cocaine
CPP and CPP was strengthened with 4 additional conditioning trials (Figures 32 & 33).
However, prior fluid consumption history via DID had no influence on CPP expression or
the number of trials required to produce CPP. Prior work with male B6 mice suggests that
CPP should have been observed with both 1 and 5 mg/kg cocaine (Cunningham et al.,
1999). Although 1 mg/kg cocaine technically produced CPP as indicated by a significant
dose × grid floor assignment interaction (thus collapsing on all fluid groups for 1 mg/kg
mice), examination of Figures 32 and 33 suggests this was not a particularly strong CPP,
at least not as strong as previously observed in male B6 mice (Cunningham et al., 1999).
One reason may be that the dosage reported in the earlier study could have been the weight
of the cocaine free base rather than the weight of the cocaine hydrochloride salt. As it was
not reported in the prior study, if the dose was indeed calculated as weight of the free base,
mice could have received approximately 12% more cocaine, thus increasing the likelihood
of stronger CPP. Another possibility is that the mice in the current study were tested during
their dark cycle whereas the vast majority of CPP tests occur during the animals’ light cycle.
Perhaps conditioning for this low dose occurs with greater efficacy if training takes place
during the light cycle. Finally, the duration of the CPP tests in the current study was 15
minutes as opposed to 30 minutes in the earlier study. Although the 15 minute duration was
chosen for the sake of consistency across both experiments in the current study, it is
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possible that this shorter testing period may not have detected group differences that may
emerge with a longer test. Indeed, some studies have shown that CPP effects may not
emerge until later in a test (Cunningham et al., 2006). Therefore, CPP was also analyzed
across each 5 minute bin of the 15 minute CPP tests. No evidence was found for
strengthened CPP towards the end of the tests (Figures 36 & 37). As such, longer CPP test
sessions may not have necessarily revealed any group differences that the 15 minute test
was unable to detect.
Caffeine has been previously shown to enhance cocaine CPP when administered
concomitantly in mice when both drugs are administered at a low doses (0.32 mg/kg
caffeine; 1.0 mg/kg cocaine) (Bedingfield et al., 1998). The only known study, however, to
directly address the effect of prior voluntary caffeine consumption on cocaine CPP by
O’Neil and colleagues (2015) found that adolescent, but not adult, consumption of caffeine
produced CPP for a 7.5 mg/kg dose of cocaine in rats. This dose is higher than either dose
of cocaine used in the current study. Therefore, neither caffeine nor ethanol consumption
history via DID appears to enhance sensitivity to the conditioned rewarding effects of lower
doses of cocaine in male B6 mice. It is possible, however that higher doses of cocaine may,
elicit group differences produced by these various DID fluid consumption histories as
evidenced by an observed effect of caffeine consumption history in Experiment 1 at the 10
mg/kg dose.

Collective Interpretation of Experiments 1 and 2
In the current study, the primary objective was to explore whether a history of
binge-like caffeine and/or ethanol consumption influenced two different domains of
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cocaine responsiveness: locomotor sensitization and conditioned reward. Only the highest
dose of cocaine (10 mg/kg) produced cross-sensitization in mice that had previously
consumed caffeine via DID and fluid consumption history had no influence on conditioned
reward. Although cross-sensitization and CPP are argued to be models reflective of abuse
liability, it is important to discuss the degree to which these phenotypes are related to each
other, as well as their associations with abuse potential.
Firstly, the complete lack of an ethanol consumption history to influence either
sensitization or CPP should be acknowledged. This was rather surprising as the existing
data reviewed above suggests that, if anything, ethanol pre-exposure would have increased
cocaine sensitivity. A history of binge-like drinking via DID has been shown to induce
substantial neurobiological and neurophysiological changes. Therefore, the model does
indeed produce levels of ethanol intake that are sufficient to produce neuroadaptation.
However, much of this previous work employed DID protocols lasting up to 6 weeks (Fritz
and Boehm II, 2016; Sparrow et al., 2012). It may therefore be that 14 days of ethanol
access in the current work was not sufficient to induce neurobiological/chemical changes
influencing cocaine sensitivity.
Nevertheless, a caffeine consumption history via DID was sufficient to produce
cross-sensitization to the locomotor stimulant, but not the conditioned rewarding effects of
cocaine. The lack of an effect on CPP, does not mean that there is little concern for the
abuse potential for cocaine, however. The rewarding components of drug consumption
have long been dissociated from drug-seeking and drug-taking in chronic drug abusers as
their motivation to obtain drugs increases over time while they report the positive effects
of consumption wane (Camí and Farré, 2003). Furthermore, animal models also

78
demonstrate that self-administration and CPP are measuring fundamentally different
processes (Bardo and Bevins, 2000). A sensitized state, however, has been associated with
increased drug-seeking behavior in operant studies. For example rodents sensitized to a
variety of psychostimulants have demonstrated an enhanced propensity to self-administer
those drugs (Piazza et al., 1990; Vezina, 2004). In addition, self-administration of
psychostimulants, including cocaine, can produce locomotor sensitization (Hooks et al.,
1994; Phillips and Di Ciano, 1996). Finally, sensitization has been demonstrated to be
predictive of relapse-like behavior potential (De Vries et al., 1998; Ferrario et al., 2005),
however this has not been consistently observed (Ahmed and Cador, 2005). Nevertheless,
it has been argued that the close overlap in neurocircuitry between sensitization and
reinstatement holds strong construct validity for the sensitization model (Steketee and
Kalivas, 2011). Furthermore, sensitization of motivation circuitry may be related, but not
entirely associated with motor effects, perhaps contributing to the previously mentioned
discordance between reinstatement and locomotor sensitization (Steketee and Kalivas,
2011). Sensitization may be reflective of a compulsory drug-seeking state due to the
increased incentive salience of drug cues (Robinson and Berridge, 2001).
Cocaine locomotor sensitization has been dissociated from reward in rodents.
Riday and colleagues demonstrated that although drugs of abuse acutely increase the
rewarding value of electrical medial forebrain bundle stimulation, mice sensitized to
cocaine did not exhibit a potentiation of stimulation reward (Riday et al., 2012).
Furthermore, cocaine CPP and sensitization responses were found to be uncorrelated within
individual rats with doses similar to those used in the current study (Seymour and Wagner,
2008) and a study with inbred strains of mice found no genetic correlation between cocaine
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sensitization and CPP (Eisener-Dorman et al., 2011). Thus, although these phenotypes may
be unrelated, they can still nevertheless be observed concurrently (Shimosato and Ohkuma,
2000).
Cocaine CPP and self-administration also appear to be separate processes. D2R
antagonists are highly effective at reducing cocaine self-administration, however they are
ineffective at influencing cocaine CPP which is instead strongly blunted by the
administration of D1R antagonists (Bardo and Bevins, 2000). CPP offers unique utility,
however, to gain important insight on the response to drug-associated environmental cues
(Tzschentke, 1998). An environment associated with a drug is likely to facilitate or allow
the opportunity to take the drug in humans. Therefore, the ability for a drug-associated
context to elicit approach behavior is an important assessment, modeling one facet of
use/abuse potential. CPP tests also occur in a drug-free state. This has construct validity for
the rewarding value of the drug as the animal makes an appetitive choice to spend time in
the context in which the drug was received without the interference of the drug’s
pharmacological effects.
Together, these findings suggest that the psychomotor stimulant response to cocaine
can be enhanced by a history of caffeine consumption. However, this may not be a
particularly persistent effect. Furthermore, neither caffeine nor ethanol consumption
histories influenced the development or expression of cocaine CPP, indicating that the
appetitive properties of cocaine-associated environmental cues were not affected by these
drinking histories. Given the association between sensitization and self-administration, it
is possible that caffeine pre-exposure may influence early interactions with cocaine which
may, in turn, increase its use/abuse potential.
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Mechanisms of Findings
The fact that cross-sensitization, but not conditioned reward, for cocaine was
altered provides some possibilities for the potential mechanisms of this observation. D2Rs
do not appear to influence cocaine CPP, however, D1Rs are highly influential (Bardo and
Bevins, 2000). However, both D1Rs and D2Rs have the capacity to influence cocaine
stimulation and sensitization (Fontana et al., 1993). The study by O’Neil and colleagues
which observed enhanced cocaine CPP and locomotor stimulation as a consequence of
adolescent caffeine consumption observed alterations in adenosine and DA receptor levels
in the nucleus accumbens which may assist in the interpretation of the observations in the
current study. They found that adolescent caffeine consumption increased D2R levels and
decreased A2AR levels in the nucleus accumbens, whereas D1R levels were unchanged
and A1R levels were increased (O'Neill et al., 2015). Furthermore rats that had a history of
adolescent caffeine consumption exhibited heightened sensitivity to the locomotor
stimulant effect of the D2R agonist quinpirole at doses that suggested an increase in
postsynaptic D2Rs. The authors attributed their observed increased locomotor response to
and CPP for cocaine to a decrease in A2AR regulation of D2Rs in the accumbens, thus
resulting in enhanced D2R signaling via cocaine-induced increases in DA. This hypothesis
is supported for their observed increase in cocaine-stimulated locomotor activity. The
A2AR antagonist MSX-3 potentiates the locomotor stimulant response to cocaine (Filip et
al., 2006), although this has yet to be assessed as a consequence of direct infusion into the
nucleus accumbens. As for decreased A2AR inhibition of the D2R as their proposed
mechanism of enhanced cocaine CPP, the aforementioned lack of D2R antagonist effects
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within the nucleus accumbens on cocaine CPP (Baker et al., 1996) is in disagreement with
this contention.
Although the current study corroborates the effect of prior caffeine consumption on
cocaine locomotor sensitivity, this was observed at a lower dose in the current study (10
mg/kg versus 15 mg/kg). Furthermore, O’Neil and colleagues (2015) observed enhanced
CPP as a result of prior caffeine consumption at a higher dose of cocaine than either used
in the current study (7.5 mg/kg versus 1 and 5 mg/kg). One factor that makes comparisons
between these two studies difficult is that the 10 mg/kg dose that elicited caffeine group
differences in cocaine stimulation was not used in the CPP experiment in the current study.
It is therefore not clear whether enhanced cocaine CPP may have also been observed at this
dose. Nevertheless, decreased A2AR inhibition of D2Rs within the nucleus accumbens via
prior caffeine consumption is a plausible mechanism of the observation in Experiment 1
that would not necessarily influence the results in Experiment 2. In fact, it is the most
reasonable mechanism to propose as no other study has addressed these scientific questions
in this manner. Future work will therefore evaluate DA and adenosine receptor levels in
the accumbens of cocaine-naïve and cocaine-treated mice in the current study to determine
whether the observations in Experiment 1 may be attributable to a similar mechanism. The
consequences of enhanced D2R signaling in the nucleus accumbens could be inhibition of
GABAergic projections to the VTA, ventral pallidum, and ventromedial prefrontal cortex,
thus relieving inhibition of this circuitry. Enhancing activity within the mesolimbocortical
circuit may therefore have problematic implications for individuals’ early interactions with
cocaine.
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Future Directions
In agreement with previous research, prior caffeine exposure enhances sensitivity
to the psychomotor stimulant properties of moderate, but not low doses of cocaine.
Additional data that would clarify the interpretation of the existing data would be the use
of a higher, consistent dose of cocaine in CPP as was used in the locomotor sensitization
experiment. This will allow for direct comparisons to be made between observations in
each paradigm. The current study unfortunately observed an effect of fluid consumption
history in Experiment 1 at the 10 mg/kg dose that was not utilized in Experiment 2. As
prior research has observed a caffeine consumption history to enhance cocaine CPP
employing a higher dose than was used in the current study (O'Neill et al., 2015), this seems
to be an essential point of clarification.
Furthermore, the effect of adolescent caffeine and ethanol co-exposure on cocaine
sensitivity is also highly relevant. Caffeinated ethanol consumption is highly popular with
adolescents and young adults (Arria et al., 2010; Marczinski, 2011). The adolescent brain
is optimally-suited for drugs to induce neuroplastic changes (Spear, 2000) and thus, may
be uniquely sensitive to the combined effects of caffeine and ethanol co-exposure. Indeed,
our lab recently observed that adolescent, but not adult B6 mice that co-consumed caffeine
and ethanol via DID exhibited additive locomotor stimulation (Fritz et al., in press). Along
with previous observations of adolescent caffeine consumption enhancing cocaine
sensitivity (O'Neill et al., 2015), this potential line of research holds promise for answering
key questions about the protracted consequences of caffeine and ethanol co-consumption.
Finally, caffeine and ethanol co-consumption also has the potential to alter
sensitivity to another highly addictive psychostimulant, methamphetamine. Excessive
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ethanol consumption has been observed in individuals abusing methamphetamine (Parsons
et al., 2007; Semple et al., 2003). Up to 60% of urban methamphetamine users have
reported frequent co-use with ethanol (Green and Mourgues, 2005) and frequency of
ethanol intoxication has been observed to be positively associated with methamphetamine
use (Furr et al., 2000). Animal studies have found that a history of ethanol exposure
sensitized striatal dopamine release in response to an acute challenge of methamphetamine
(Nishiguchi et al., 2002) and a genetic predisposition for high ethanol intake enhances the
acute locomotor stimulant response to combined methamphetamine and ethanol in rats
(Yamauchi et al., 2000). Caffeine use statistics among methamphetamine abusers was not
readily available, however it is known that methamphetamine is often ‘cut’ with caffeine
(Kuribara, 1994) and has even been intentionally combined with caffeine in a tablet
referred to as ‘Ya-Ba’ in Thailand (Sinchai et al., 2011). While it may seem that the primary
reason for this practice is to reduce the cost of production and/or consumption, findings
from animal studies suggest that caffeine may greatly amplify the stimulant effect of low,
to moderate doses of methamphetamine (Fujii et al., 1989; Kuribara, 1994).
Methamphetamine has been theorized to work through reversal of both the vesicular
monoamine transporter and the DAT, releasing vesicular stores of dopamine inside the
presynaptic terminal which then flood the synapse (Fleckenstein et al., 2007). In addition,
the activation of D2Rs has been demonstrated to play an important role in
methamphetamine locomotor stimulation and sensitization (Kelly et al., 2008). Repeated
cycles of binge caffeine and alcohol co-exposure may therefore have the capacity to alter
neural sensitivity to methamphetamine.
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In conclusion, caffeine may not be as harmless as previously thought. For most
individuals, caffeine is likely the first drug intentionally consumed with the goal of altering
one’s psychological state. In addition, it is the most used psychoactive substance in the
world (Fredholm et al., 1999). Individuals experimenting with potent psychostimulants
(such as cocaine), who readily consume caffeine, may respond more strongly to their
stimulant properties. This enhanced response may ultimately influence their later
interactions with these substances. As such, the potential risks associated with significant
caffeine use should be noted as energy drink consumption is increasingly popular and has
been linked to polydrug abuse (Arria et al., 2010).
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APPENDIX: FIGURES

Figure 1. Schematic of ethanol/caffeine adenosine pharmacology. Figure from from López-Cruz et al.
(2013). Ethanol increases adenosine signaling by 1) increasing adenosine as a product of ethanol metabolism
2,3) inhibiting transport of extracellular adenosine into the cell and instead, releasing adenosine through its
transporter. 4) Caffeine is a nonselective adenosine receptor antagonist. Collectively, the positive dopamine
signaling effects of both caffeine and ethanol, and the inhibition of ethanol-induced adenosine receptor
regulation of dopamine receptors by caffeine, may allow for an additive effect of caffeine and ethanol on
dopamine signaling.
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Figure 2. Relationship between caffeine intake/blood content. Following day 14 of DID, periorbital blood
samples were taken from C and EC mice in the study by Fritz et al. (2014). Blood caffeine content was later
analyzed by high performance liquid chromatography. Caffeine intake was significantly predictive of blood
caffeine concentration (N = 50).
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Figure 3. Relationship between caffeine intake and blood paraxanthine content. Following day 14 of
DID, periorbital blood samples were taken from C and EC mice in the study by Fritz et al. (2014). Blood
paraxanthine content analysis was later conducted by high performance liquid chromatography. Caffeine
intake was significantly predictive of blood paraxanthine concentration (N = 50).
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Figure 4. Pilot study data. Following 14 days of DID, mice received an injection of saline in order to
habituate the animals to the handling/injection procedure as well as the apparatus for 2 days. The following
day, mice received either saline or cocaine (10 mg/kg; i.p.) and activity was recorded for 15 minutes. There
was statistical trend (p = 0.07) for particularly robust cocaine induced locomotor stimulation in EC mice (n
= 5-12).

144

Figure 5. Standard DID setup. Figure from Thiele et al. (2014) depicting a typical cage setup for DID
drinking sessions.
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Figure 6. AccuScan activity monitor.
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Figure 7. CPP setup for AccuScan activity monitors. Example of a floor cue orientation setup for a CPP
test in Experiment 2.
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Figure 8. Timeline for Experiment 1.
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Figure 9. Relationship between ethanol intake/blood levels. Following day 14 of DID, periorbital blood
samples were taken from E and EC mice for ethanol content analysis in the study by Fritz et al. (2014).
Ethanol intake was highly predictive of BEC, p < 0.001 (N = 40).
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Figure 10. Timeline for Experiment 2.
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Figure 11. CPP Floor textures. Grid (left) and hole (right) floor textures used in the CPP protocol in
Experiment 2.
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Figure 12. Experiment 1: Fluid intake. Total fluid intake (ml/kg) over the course of the 14-day DID
procedure Experiment 1. Mice that consumed caffeine (C,EC) consumed significantly more fluid than mice
that did not over the course of the DID procedure. **p < 0.01 versus mice that did not have access to caffeine
(E,W) (n = 58-69).
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Figure 13. Experiment 1: Caffeine intake. Total caffeine intake (mg/kg) over the course of the 14-day DID
procedure. Mice in the C group consumed significantly more caffeine early on in the DID phase than EC
mice. *p < 0.05 versus EC (n = 60-67).
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Figure 14. Experiment 1: Ethanol intake. Total ethanol intake (g/kg) over the course of the 14-day DID
procedure. Mice in the E and EC groups consumed equivalent amounts of ethanol throughout the DID phase
of the experiment (n = 67-69).
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Figure 15. Experiment 1: Habituation Activity. Habituation activity during the first two days of the
sensitization protocol. Mice that had consumed caffeine (C,EC) in DID were significantly more active than
those that had not on Day 1. *p < 0.05 versus mice that did not have access to caffeine in DID (W, E) (n =
58-69).
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Figure 16. Experiment 1: Caffeine group activity. Activity throughout the 11-day sensitization protocol
in mice that consumed caffeine only in the DID phase of the experiment. Mice that received repeated cocaine
were significantly more stimulated than those that received acute cocaine on the final day of the sensitization
protocol. *p < 0.05, **p < 0.01 RC versus AC of the same dose group (n = 11-13).
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Figure 17. Experiment 1: Ethanol group activity. Activity throughout the 11-day sensitization protocol in
mice that consumed ethanol only in the DID phase of the experiment. Repeated cocaine did not differentially
influence cocaine-induced locomotor stimulation relative to an acute injection (n = 12-15).
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Figure 18. Experiment 1: Ethanol + caffeine group activity. Activity throughout the 11-day sensitization
protocol in mice that consumed combined caffeine and ethanol in the DID phase of the experiment. Mice
that received repeated 10 mg/kg cocaine were significantly more stimulated than those that received acute 10
mg/kg cocaine on the final day of the sensitization protocol. *p < 0.05 RC versus AC (n = 11-15).
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Figure 19. Experiment 1: Water group activity. Activity throughout the 11-day sensitization protocol in
mice that consumed water only in the DID phase of the experiment. Mice that received repeated 10 mg/kg
cocaine were significantly more stimulated than those that received acute 10 mg/kg cocaine on the final day
of the sensitization protocol. ***p < 0.001 RC versus AC (n = 11-13).
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Figure 20. Experiment 1: Day 3 activity. Mice in the RC groups received their first dose of cocaine on Day
3 whereas all other groups received saline. Mice that received cocaine (RC) were significantly more active
than those that did not. In addition, mice that received 10 mg/kg cocaine were also significantly more
stimulated than mice that had received 5 mg/kg of cocaine (p < 0.001). Finally, 10 mg/kg cocaine stimulated
mice that had consumed caffeine (C,EC) to a significantly greater degree than those that did not previously
consume caffeine in DID (E,W). Although CN mice were not included in the analysis, their activity is
presented here as a contextual baseline measure. ***p < 0.001 RC 10 mg/kg versus RC 5 mg/kg; ##p < 0.01
versus RC 10 mg/kg mice that had not previously consumed caffeine (E,W) (n = 11-15).
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Figure 21. Experiment 1: Day 11 activity. Mice in the RC groups received their fifth dose of cocaine on
Day11 whereas AC groups received their first dose. Mice that received repeated cocaine (RC) were
significantly more active than AC mice. In addition, mice that received 10 mg/kg cocaine were also
significantly more stimulated than mice that had received 5 mg/kg of cocaine (p < 0.001). Although CN mice
were not included in the analysis, their activity is presented here as a contextual baseline measure. ***p <
0.001 RC versus AC mice; (n = 11-15).
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Figure 22. Experiment 1: Sensitization scores. Sensitization response in mice that received repeated
cocaine. SENZ scores were computed (Day 11 activity – Day 3 activity) for mice that had repeatedly received
cocaine (RC) in Experiment 1. A) Among mice receiving 5 mg/kg cocaine, only EC and W mice achieved
significant SENZ scores. B) Among mice receiving 10 mg/kg cocaine, only W mice achieved a significant
SENZ score. *p < 0.05, **p < 0.01, ***p < 0.001 versus ‘0’ (n = 11-15).
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Figure 23. Experiment 1: Caffeine/ethanol intake and Day 3 activity regressions. Neither prior DID
caffeine or ethanol intake is predictive of 10 mg/kg cocaine response on Day 3. Regression analysis
determined that the observed enhanced stimulant response to 10 mg/kg cocaine in mice that had previously
consumed A) caffeine (C,EC) was not influenced by the relative amounts of caffeine consumed. B) Prior
ethanol intake (E,EC) in DID also had no effect on the Day 3 response to 10 mg/kg cocaine (N’s = 27-29).
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Figure 24. Experiment 2: Total fluid intake. Total fluid intake (ml/kg) over the course of the 14-day DID
procedure in Experiment 2. Mice that consumed ethanol (E,EC) consumed significantly more fluid than mice
that did not over the course of the DID procedure. *p < 0.05 versus mice that did not have access to ethanol
(C,W) (n = 57-60).
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Figure 25. Experiment 2: Caffeine intake. Total caffeine (mg/kg) intake over the course of the 14-day DID
procedure in Experiment 2. EC mice consumed significantly more caffeine than C mice towards the end of
the 14-day DID procedure. #p < 0.05 versus C (n = 57-60).
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Figure 26. Experiment 2: Ethanol intake. Total ethanol intake (g/kg) over the course of the 14-day DID
procedure in Experiment 2. Mice in the E and EC groups consumed equivalent amounts of ethanol throughout
the DID phase of the experiment (n = 58-60).
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Figure 27. Experiment 2: Habituation activity. Habituation activity during the first day of the CPP protocol.
Prior fluid consumption in DID produced no differences in baseline activity on Day 1 of the CPP protocol (n
= 58-69).
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Figure 28. Experiment 2: CS- trial activity. Activity during cocaine-free CS- conditioning trials. Animals
receiving 5 mg/kg cocaine on CS+ trials were significantly more active during drug-free CS- trials than mice
that had received 1 mg/kg or saline. Furthermore this effect was particularly apparent in mice that previously
consumed ethanol via DID (E,EC) over the last 3 trials. ***p < 0.001 versus 0 mg/kg and 1 mg/kg; #p < 0.05
for significant ethanol × dose × trial interaction with mice that had consumed ethanol and received 5 mg/kg
cocaine being significantly more active than 0 mg/kg and 1 mg/kg mice over the last 3 trials relative to mice
that had not consumed ethanol (C,W) (n = 9-25).
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Figure 29. Experiment 2: CS+ trial activity. Activity during cocaine CS+ conditioning trials. Animals
receiving 5 mg/kg cocaine on CS+ trials were significantly more active than mice that had received 1 mg/kg
or saline. Furthermore, mice that previously consumed ethanol via DID (E,EC) were significantly less active
over the last 4 trials than mice that had not (C,W). ***p < 0.001 versus 0 mg/kg and 1 mg/kg; ^p < 0.05 for
significant ethanol × trial interaction with mice that had consumed ethanol being significantly less active
over the last 4 trials relative to mice that had not consumed ethanol (C,W) (n = 9-25).
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Figure 30. Experiment 2: Control group test grid floor time. Time spent on the grid floor during the CPP
tests in control 0 mg/kg mice. Previous DID fluid consumption did not influence time spent on the grid floor
during the CPP tests in saline control CN mice (n = 9-11).
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Figure 31. Experiment 2: Control group test activity. Activity during the CPP tests in control CN mice.
Previous DID fluid consumption did not influence basal activity during the CPP tests in saline control CN
mice (n = 9-11).
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Figure 32. Experiment 2: Test 1 grid floor time. Time spent on the grid floor for mice that had cocaine
previously paired with the grid (G+) or hole (G-) floor in Test 1. G+ mice generally spent more time on the
grid floor than G- mice. In addition, this difference was far more pronounced in mice that had received 5
mg/kg rather than 1 mg/kg cocaine (dose × grid floor assignment interaction, p < 0.001). ***p < 0.001 versus
G- (n = 11-15 per dose/floor assignment combination).
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Figure 33. Experiment 2: Test 2 grid floor time. Time spent on the grid floor for mice that had cocaine
previously paired with the grid (G+) or hole (G-) floor in Test 2. G+ mice generally spent more time on the
grid floor than G- mice. In addition, this difference was far more pronounced in mice that had received 5
mg/kg rather than 1 mg/kg cocaine (dose × grid floor assignment interaction, p < 0.001). ***p < 0.001 versus
G- (n = 11-15 per dose/floor assignment combination).
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Figure 34. Experiment 2: Time on drug paired floor. Total time spent on the drug-paired floor (either grid
or hole) during the CPP tests. Mice that received 5 mg/kg cocaine spent significantly more time on the drugpaired floor than mice that received 1 mg/kg cocaine. ***p < 0.001 for main effect of dose versus 1 mg/kg
(n = 23-25).
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Figure 35. Experiment 2: CPP test activity. Activity during the drug-free CPP tests in mice that received
cocaine during conditioning. Mice that had received 5 mg/kg cocaine during CS+ conditioning trials were
significantly more active during the drug-free CPP tests than those that had received 1 mg/kg cocaine. ***p
< 0.001 versus 1 mg/kg (n = 23-25).
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Figure 36. Experiment 2: Within session CPP. Time spent on the drug floor during CPP Tests. The time
that mice spent on the drug-paired floor was not differently expressed across each of the 5-minute bins of in
the CPP tests (n = 23-25).
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Figure 37. Experiment 2: Test activity/CPP regression. Relationship between activity and time spent on
the drug-paired floor during CPP tests. Activity was positively predictive of time spent on the drug-paired
floor in A) Test 1, but not B) Test 2 (N = 196).
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Figure 38. Experiment 2: Prior caffeine/ethanol intake and CPP regression. Relationship between prior
caffeine and ethanol intake with time spent on the drug floor during CPP tests. Neither prior A,C) caffeine
or B,D) ethanol consumption via DID influenced the time spent on the drug paired floor in either CPP test (n
= 98-99).
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